???????????? ??? ?????? ?????? ????????? ????????? ??????????????? ????????? ????????? ????????? ????????? by Choi, Jun-Ho
 
 
저 시-비 리- 경 지 2.0 한민  
는 아래  조건  르는 경 에 한하여 게 
l  저 물  복제, 포, 전송, 전시, 공연  송할 수 습니다.  
다 과 같  조건  라야 합니다: 
l 하는,  저 물  나 포  경 ,  저 물에 적 된 허락조건
 명확하게 나타내어야 합니다.  
l 저 터  허가를 면 러한 조건들  적 되지 않습니다.  
저 에 른  리는  내 에 하여 향  지 않습니다. 




저 시. 하는 원저 를 시하여야 합니다. 
비 리. 하는  저 물  리 목적  할 수 없습니다. 




















Department of Chemistry 









Three-Component Synthesis of Quinolines  
Based on  






















Department of Chemistry 
    
 
 
Ulsan National Institute of Science and Technology 
 
Three-Component Synthesis of Quinolines  
Based on  








A thesis/dissertation submitted to 
Ulsan National Institute of Science and Technology 
in partial fulfillment of the 
requirements for the degree of 













Prof. Cheol-Min Park 
Three-Component Synthesis of Quinolines  
Based on  
Radical Cascade Visible-Light Photoredox Catalysis 










This certifies that the thesis/dissertation of Jun-Ho Choi is approved. 
 





Advisor: Cheol-Min Park 
 
___________________________ 
Committee member: Wonyoung Choe 
 
 ___________________________ 
Committee member: Sung You Hong 
 
 ___________________________ 
Committee member: Young S. Park 
 
 ___________________________ 
Committee member: Sang Kook Woo 
Three-Component Synthesis of Quinolines  
Based on  
Radical Cascade Visible-Light Photoredox Catalysis 
1 
 
Table of Contents 
 
Abstract ........................................................................................................................................... 4 
List of Figures .................................................................................................................................. 5 
List of Schemes ................................................................................................................................ 6 
List of Tables .................................................................................................................................... 8 
Abbreviations .................................................................................................................................. 9 
Chapter 1. Background of Quinoline ........................................................................................ 11 
1.1. Quinolines in natural compounds and drugs ....................................................................... 12 
1.1.1. Quinolines in natural compounds ................................................................................. 12 
1.1.2. Quinolines in drugs ..................................................................................................... 13 
1.2. Classical synthesis of quinoline .......................................................................................... 14 
1.2.1. Gould–Jacobs reaction ................................................................................................ 14 
1.2.2. Friedländer reaction .................................................................................................... 14 
1.2.3. Pfitzinger reaction ....................................................................................................... 15 
1.2.4. Skraup/Doebner-von Miller reaction ............................................................................ 15 
1.2.5. Combes/Conrad-Limpach reaction ............................................................................... 16 
Chapter 2. Photoredox catalysis and Examples in Quinoline Synthesis ................................... 17 
2.1. Multicomponent reaction (MCR) ....................................................................................... 18 
2.2. Visible-light-mediated photoredox catalysis ....................................................................... 18 
2.2.1. Radical generation from conventional methods to photoredox catalysis........................ 18 
2.2.2. General characteristic of photocatalysts ....................................................................... 19 
2.2.3. Oxidative/reductive quenching cycles of photoredox catalysts ..................................... 21 
2.3. Synthesis of quinolines based on photoredox catalysis ....................................................... 22 
2.3.1. From iminyl or imidoyl radicals................................................................................... 22 
2.3.2. Dehydrogenation of tetrahydroquinolines .................................................................... 24 
2.3.3. Povarov cyclization ..................................................................................................... 24 
2 
 
2.3.4. N-Propargyl aniline/imine ............................................................................................ 26 
2.3.5. Aniline derivatives ....................................................................................................... 27 
Chapter 3. Three-Component Synthesis of Quinolines based on Radical Cascade Visible-light 
Photoredox Catalysis ................................................................................................................. 29 
3.1. Design of synthesis of quinoline......................................................................................... 30 
3.2. Reaction optimization for synthesis of quinoline ................................................................ 31 
3.3. Preliminary result .............................................................................................................. 34 
3.4. Second reaction optimization ............................................................................................. 36 
3.5. Substrate scope in β-aminoacrylate .................................................................................... 39 
3.6. Substrate scope in C-C unsaturated bonds and halides ........................................................ 41 
3.6.1. Substrate scope in maleimide ....................................................................................... 41 
3.6.2. Substrate scope in activated unsaturated C-C bonds ..................................................... 42 
3.6.3. Substrate scope with Perfluorinated substituents .......................................................... 44 
3.7. Mechanistic studies ............................................................................................................ 45 
3.7.1. Control experiments .................................................................................................... 45 
3.7.2. Fluorescence quenching study ..................................................................................... 49 
3.7.3. Visible-light on/off experiment .................................................................................... 52 
3.7.4. Plausible Mechanism ................................................................................................... 53 
3.8. Experimental procedures and data ...................................................................................... 54 
3.8.1. General methods .......................................................................................................... 54 
3.8.2. Synthetic procedures for β-aminoacrylates ................................................................... 55 
3.8.2.1. General procedure A (for 1a ~ 1l) .......................................................................... 55 
3.8.2.2. General procedure B (for 1m) ............................................................................... 58 
3.8.3. Synthetic procedures for maleimide ............................................................................. 59 
3.8.3.1. General Procedure C (for 3n, 3o, 3r, 3s and 3t) ..................................................... 59 
3.8.3.2. General procedure D (for 3q) ................................................................................ 61 
3.8.3.3. General procedure E (for 3u) ................................................................................. 61 
3 
 
3.8.3.4. General procedure F (for 3v) ................................................................................. 63 
3.8.4. Synthetic procedures for other coupling partners .......................................................... 64 
3.8.4.1. (Z)-ethyl 3-cyanoacrylate (3x) ............................................................................... 64 
3.8.4.2. (E)-dimethyl hex-2-en-4-ynedioate (3z)................................................................. 65 
3.8.4.3. Togni’s reagent II (2ab)......................................................................................... 66 
3.8.5. Procedure for optimization studies ............................................................................... 68 
3.8.5.1. First optimized reaction condition ......................................................................... 68 
3.8.5.2. Second optimized reaction condition ..................................................................... 69 
3.8.6. Procedures for Three-Component Synthesis of Quinolines based on Radical Cascade 
Visible-Light Photoredox Catalysis ....................................................................................... 69 
3.8.7. Characterization data of Quinolines 4 .......................................................................... 70 
3.8.8. Control experiments .................................................................................................... 88 
3.8.8.1. Control experiment (2) .......................................................................................... 88 
3.8.8.2. Control experiment (3) .......................................................................................... 89 
3.8.9. Procedure for visible-light on/off experiment ............................................................... 90 
3.8.10. Cyclic voltammetry data ............................................................................................ 90 
3.8.10.1. 4-methoxy-N,N-diphenylaniline .......................................................................... 90 
3.8.11. NMR spectra ............................................................................................................. 91 
References .................................................................................................................................... 137 







Recently, irradiation of visible light photoredox catalyst has been widely used to drive 
transformation of organic molecules though the highly desirable processes.1-5 Absorption of visible light 
induces the long-lived excited-triplet state of the photocatalyst. The returning from this excited state to 
the bench state of the catalyst leads single-electron-transfer (SET), transforming the reacting substrates 
into radical intermediates. The radical cation/anion intermediates show their reactivity which is 
basically differentiated from those of electronically ground state of molecules.  
Multicomponent reaction (MCR) serves as a powerful tool, employing three or more simple 
building blocks to produce complex molecular frameworks in a single step.6-9 Given its advantages of 
rapid access to structural complexity, MCR has been adopted as a valuable means for the discovery of 
bioactive compounds.10,11 As such, photoredox catalysis has been explored in the context of MCR.12-15 
However, the limited examples are mostly based on radical-polar crossover mechanisms, in which the 
process is in operation for initial coupling of two reactants, while a third component is incorporated via 
a polar process.16-26 Although this approach is useful, quenching of radical processes by redox catalysts 
entailing the involvement of polar processes poses limitations in the scope of coupling partners. To the 
best of our knowledge, MCR with three consecutive bond formation based on radical processes via 
visible-light photoredox catalysis has not been reported.  
Due to their utilities, significant efforts have been made to develop efficient synthetic methods 
for quinolines. However, the conventional methods rely on condensation under harsh conditions and 
more recent developments are limited to transitional metal-catalyzed27-29 and iodine-mediated 
synthesis.30-32 Here, a successful development of a new tandem radical cyclization based on visible-
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1.1. Quinolines in natural compounds and drugs 
 
In nature, it is almost impossible to find the biologically active, therapeutic compounds without 
possession of heterocyclic scaffolds. Among the approximately 20 million natural/synthetic compounds 
identified by the end of the second millennium, more than half are heterocyclic compounds. Numerous 
famous natural drugs, including papaverine, theobromine, quinine, emetine, theophylline, codeine and 
morphine, contain heterocyclic scaffolds. Plus, most of important synthetic medications such as 
diazepam, chlorpromazine, isoniazid, metronidazole, are also heterocyclic compounds. Among the 
diverse heterocycles, nitrogen-containing heterocyclic (N-heterocyclic) compounds are especially the 
most common features in both natural and synthetic drugs. Among the best-selling 200 small molecule 
pharmaceuticals worldwide, 74% of them are the N-heterocyclic compounds.33 Therefore, seeking the 
easier way to forming N-heterocyclic compounds has been the most important issue in view of synthetic 
chemistry in a long period. 
1.1.1. Quinolines in natural compounds 
 
Quinoline, one of the most important N-heterocyclic compounds, has attracted enormous 
attention when it is discovered 200 years ago because of its significant bioactivity. From 19th century, 
a number of natural compounds containing quinoline moiety have been isolated from natural sources 
and studied by worldwide researchers. There are two representatives, quinine and camptothecin (CPT), 
which are two of the most famous quinoline-containing compounds. They opened new horizons for 
drug development in antimalarial and anticancer fields (Scheme 1-1). 
 
Scheme 1-1. The most famous quinoline alkaloids, quinine and CPT 
 
Quinine, which was isolated in 1820 from the bark of Cinchona tree, was the major treatment 
for malaria before it was replaced by other advanced treatments such as quinacrine, chloroquine and 
primaquine. It is known that its toxicity against malaria pathogen interferes the ability of malaria 
parasite, inhibiting the metabolism and ingestion of hemoglobin.  
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Camptothecin (CPT), which was isolated in 1966 from the bark and stem of Camptotheca 
acuminate, was widely used as treatment to cancer in China. As a topoisomerase poison, it has been 
used as preliminary clinical trials for broad range of cancers, including breast, ovarian, colon, lung, and 
stomach. Due to its poor solubility, numerous analogues of CPT have been developed by synthetic and 
medicinal chemists.  
1.1.2. Quinolines in drugs 
 
Moreover, more than 200 quinoline alkaloids showed expansive range of biological activities 
on not only antimalarial and anticancer but also antibacterial, antifungal, antiviral and anti-
inflammatory effects.34 The following examples are the famous quinoline-containing medications, 
which are successfully supplied as treatments of important diseases on a huge scale in the world 
(Scheme 1-2). 
Lenvatinib is known to act as a kinase inhibitor, inhibiting the signaling between cancerogenic 
proteins (VEGFR1, VEGFR2 and VEGFR3 kinases) in thyroid cancer.35 It is treated for differentiated 
thyroid cancer, which has not been successful with the treatment of radioactive iodine. In combination 
with everolimus, it is used as treatment to advanced renal cell carcinoma for patient who has experienced 
anti-angiogenic therapy before. After approval of U.S. FDA in 2016, it is being sold worldwide on a 
$61.7 million scale. 
Montelukast is one of leukotriene receptor antagonists for the treatment of asthma and allergic 
coryza, opposing the act of leukotriene which is the inflammatory mediator in immune system. Blocking 
of leukotriene results in the suppressed inflammation and relaxation of smooth muscle in lungs. As a 
result, Montelukast has been a solution for effective prevention and long-term management of asthma. 
After approval of U.S. FDA in 1998, it is being sold worldwide on a $70.8 million scale. 
 
Scheme 1-2. Two of top-selling quinoline-containing medications 
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1.2. Classical synthesis of quinoline 
 
Classical approaches to synthesis of quinoline generally employed simple aniline, proceeding 
condensation with carbonyl groups. So far numerous synthetic protocols to quinoline scaffold have been 
developed. Among them, the most famous named reactions for the synthesis of quinoline are described 
below. 
1.2.1. Gould–Jacobs reaction 
 
The Gould-Jacobs reaction is a named reaction for preparation of 4-hydroxyquinoline 
derivatives (Scheme 1-3). It starts with condensation between aniline and diethyl 
ethoxymethylenemalonate, followed by substitution. A 6 electron cyclization results in the loss of 
second ethanol molecule and tautomerization, forming 4-hydroxy-3-carboalkoxyquinoline. 
Saponification followed by decarboxylation produces 4-hydroxyquinoline. This protocol enables to 
prepare various drugs containing 4-hydroxyquinoline as a core scaffold.36 
 
Scheme 1-3. General scheme of Gould–Jacobs reaction 
1.2.2. Friedländer reaction 
 
The Friedländer reaction is a named reaction between 2-aminobenzaldehyde and ketone for 
preparation of quinoline (Scheme 1-4). It is catalyzed by a base or acid, proceeding via condensation 
and double cyclodehydration. The reactive α-methylene group of ketone undergoes aldol-condensation 
to produce aldol-adduct, then elimination step results in the loss of water. Another loss of water in 
formation of imine forms variously functionalized quinoline.37 
 




1.2.3. Pfitzinger reaction 
 
The Pfitzinger reaction is a named reaction for preparation of quinoline-4-carboxylic acid from 
isatin and a carbonyl compound in presence of strong base (Scheme 1-5). The hydrolysis of amide bond 
with base in isatin gives keto-acid, then condensation between resulted aniline and a ketone forms imine 
intermediate. Enamine, which has come from the imine through tautomerization, cyclizes to from the 
desired quinoline after dehydration. The Pfitzinger reaction is one of extension of the Friedländer 
reaction, but it utilizes the more stable isatin varieties than unstable 2-aminobenzaldehyde.38 
 
Scheme 1-5. General scheme of Pfitzinger reaction 
1.2.4. Skraup/Doebner-von Miller reaction 
 
Both the Skraup reaction and the Doebner–von Miller reaction are organic reactions for 
formation of quinolines, utilizing an aniline and α,β-unsaturated carbonyl compounds (Scheme 1-6). In 
the Skraup reaction, the α,β-unsaturated carbonyl compound (acrolein) is prepared in-situ through 
dehydration of glycerol in acidic condition. Nucleophilic attack from aniline to acrolein results in 
propionaldehyde intermediate, then following intramolecular electrophilic attack from aromatic ring to 
the protonated aldehyde group yields concomitant cyclization.39 In the Doebner–von Miller reaction, 
2,3 and 4-substituted quinoline can be prepared when highly substituted α,β-unsaturated carbonyl 
compound is employed in place of the simple acrolein. Both reactions have fundamental drawbacks in 
that they require strong oxidants and highly acidic reaction conditions.40 
 
Scheme 1-6. General scheme of Skraup/Doebner–von Miller reaction 
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1.2.5. Combes/Conrad-Limpach reaction 
 
Both the Combes reaction and the Conrad-Limpach reaction involve the condensation of 
aniline with ketones (1,3-diketone and β-ketoester; the Combes reaction and the Conrad-Limpach 
reaction, respectively), forming Schiff bases (Scheme 1-7). The Schiff bases undergo acid-catalyzed 
cyclization from each enamine or imine intermediate (tautomerization). The resulted product in the 
Combes reaction is 2,4-substituted quinoline, which can be differentiated from the substituted 4-
hydroxyquinoline in the Conrad-Limpach reaction. These reactions also require the use of strong base 
and high temperature when cyclodehydration is proceeded.41 
 
Scheme 1-7. General scheme of Combes/Conrad–Limpach reaction 
In conclusion, even though there are various modified version of these named reaction, most 
of them still require harsh conditions such as high reaction temperature, use of hazardous (transitional 
metal) catalysts, acid or base and solvents, tiresome procedure for work-up, long reaction time, 
unsatisfactory regioselectivity and involvement of specific functional groups. These are potent burden 
to environment in aspect of sustainable development of methodology. Therefore, simple and greener 













Chapter 2. Photoredox catalysis and 




2.1. Multicomponent reaction (MCR) 
 
Multicomponent reaction (MCR) is a chemical transformation in which three or more starting 
materials participate in a single reaction as building blocks to form a product. The newly formed final 
product contains all or most of the atoms of starting materials, minimizing generation of byproduct. 
Therefore, MCR is highly ideal methodology in the view of atom economy. Compared with stepwise 
synthetic route, the target molecule can be achieved faster with much fewer steps in MCR strategy. In 
other words, MCR enables to access a shortcut to highly-functionalized complex molecule in a one-pot, 
whereas the sequential synthesis requires the greater effort and resources such as solvent, reagents and 
catalysts. 
 
2.2. Visible-light-mediated photoredox catalysis 
 
2.2.1. Radical generation from conventional methods to photoredox catalysis 
 
In organic chemistry, radical intermediate indicates the molecule possessing an unpaired 
electron, which is in situ generated during the reaction under specific reaction conditions. The 
conventional methods depend on the use of toxic regents such as radical initiators and stoichiometric 
oxidant/reductants. Also, they require harsh conditions involving high reaction temperature or high-
energy ultraviolet light for irradiation. Therefore, these methods are usually accompanied by limitations 
such as chemical wastes from the toxic reagents, the use of specific equipments and generation of 
undesired radical species.42 
In modern organic chemistry, development of benign, sustainable and eco-friendly synthetic 
methodologies has been highly demanded. Recently, photoredox catalysis has received a great attention 
because of its potential.43-49 Photocatalysts are excited by visible light, which is mild and abundant in 
limitless sunlight. The use of visible light does not lead any deleterious side reactions, because most of 
organic molecules are not excited by visible light. Plus, photoredox catalysis does not require any 
specific reactor, on the other words, normal glassware is sufficient to carry the reaction under visible 
light. In the catalytic cycle, it does not require the use of external oxidant and reductant because the 
photocatalysts act as internal oxidant/reductant themselves. The catalytic reaction usually proceeds at 




2.2.2. General characteristic of photocatalysts 
 
Photoredox catalysts usually consist of a central metal and surrounding polypyridyl ligands. 
Iridium and ruthenium complexes are frequently used in photoredox catalysis. Their redox potentials 
of the complexes are determined by the electronic properties of ligands and central metals. The tuning 
of redox potential, which can be a solution for improvement of reaction efficiency, can be achieved by 
modification of the structure of the ligands or replacement of central metals.50 Not only limited to the 
metallic catalysts, but also organic photoredox catalysts such as eosin Y, rose bengal exhibit the similar 
reactivity, extending to metal-free photocatalysis.51 
Among various photocatalysts, [Ru(bpy)3]
2+ is the most famous photocatalyst and well-
investigated because of its exceptional photochemical properties. The excitation event of [Ru(bpy)3]
2+ 
via visible light irradiation can be explained by its orbital energy diagram. (Figure 2-1) In the octahedral 
complex of [Ru(bpy)3]
2+, its HOMO is located in dt2g(M) orbital of central Ru
II whereas its LUMO is 
located in π*(L) orbital of its ligands. Under the irradiation of visible light, one electron from the HOMO 
of RuII is promoted to the ligand-centered LUMO without conversion of its spin, resulting in excited 
singlet state (S1) of the complex. This promotion is attributed by the absorption of visible light, of 
which λmax is 452 nm. This transition is named metal-to-ligand charge transfer (MLCT). Subsequently, 
a rapid spin flipping of the electron in π*(L) orbital is followed, called intersystem crossing (ISC). 
 




Finally, the excited triplet state (T1) of [Ru(bpy)3]
2+
 possesses both the oxidized Ru
III and 
reduced ligand. The oxidized RuIII has a vacancy to fill one electron, therefore acts as a strong oxidant, 
on the other hand, the reduced polypyridyl ligand has a high energy electron, which is willing to reduce 
organic substrates. The excited triplet state of [Ru(bpy)3]
2+ has significantly extended lifetime (τ = 
approximately 1.1 μs), which makes it possible to carry chemical transformations via intermolecular 
single-electron-transfer process.52-54 It is worthy to note that the overall charge of the excited complex 
is not changed. 
 
Figure 2-2. Brief Jablonski diagram for a typical photocatalyst 
This process can be also explained by the brief Jablonski diagram. As described, the transition 
from the ground to the triplet-excited state is resulted from the absorption of photon from visible light. 
After MLCT and ISC, the long-lived, stable triplet-excited photocatalyst can be quenched by two 
possible pathways, including single-electron-transfer (SET) and energy transfer (ET). In this project, 




2.2.3. Oxidative/reductive quenching cycles of photoredox catalysts 
 
As noted in section 2.2.2, the ground state of [Ru(bpy)3]
2+ (M) can be activated by irradiation 
of visible light to form its excited triplet state (*M) through MLCT and ISC. The excited photocatalyst 
is finally able to participate in two opposed quenching cycles; oxidative quenching cycle and reductive 
quenching cycle. In each quenching process, *[Ru(bpy)3]
2+ interacts with organic substrates, either 
electron donor (D) or acceptor (A), through single-electron-transfer (SET). *[Ru(bpy)3]
2+ can 
simultaneously act as a strong oxidant or reductant depending on the properties of substrates. (Figure 
2-3) 
 




In reductive quenching cycle, the excited photocatalyst is reduced first then re-oxidized.  
(i) *[Ru(bpy)3]
2+ (*M) obtains one electron from electron donor (D) to fill t2g(M) orbital of ruthenium, 
resulting in the formation of radical cation (D•+) and [Ru(bpy)3]
+ (M-). (ii) Then, the reduced [Ru(bpy)3]
+  
 (M-) gives up an electron from 3π*(L) orbital to the electron acceptor (A), resulting in the 
formation of radical anion (A•-) and regeneration of ground-state [Ru(bpy)3]
2+ (M). 
 On the other hand, in oxidative quenching cycle, the excited photocatalyst is oxidized first then 
reduced again. (iii) *[Ru(bpy)3]
2+ (*M) loses one electron from 3π*(L) orbital of ligand to electron 
acceptor (A), resulting in the formation of radical anion (A•-) and [Ru(bpy)3]
3+ (M+). (iv) Then, the 
oxidized [Ru(bpy)3]
3+ (M+) gains an electron from the electron donor (D), resulting in the formation of 
radical cation (D•+) and regeneration of ground-state [Ru(bpy)3]
2+ (M). 
 The meaning of oxidative/reductive can be ambiguous. Oxidative originates from the oxidation 
of *[Ru(bpy)3]
2+ (*M) with reduction of electron donor (D). On the contrary, reductive originates from 
the reduction of *[Ru(bpy)3]
2+ (*M) with oxidation of electron acceptor (A). It is worthy to note that 
each of quenching cycles processes its transformation via overall redox-neutral SET pathway. 
 
2.3. Synthesis of quinolines based on photoredox catalysis 
 
As discussed in chapter 1, quinoline exhibits an extensive range of its biological activities.55-
60 Moreover, it is often employed to fluorescent agents due to its small size. Also, it is widely applied 
in DNA, RNA imaging and chemo-sensing because of its tendency not only to coordinate H-bonding 
of protein and nucleic acid, but also to chelate with metals.61-64 Considering the potential of quinoline 
in industry, development of milder, greener and facile synthesis of it has received a great attention. 
Recently, the development of methodologies based on visible-light-mediated strategy is favored as a 
greener, sustainable approach. Therefore, a number of quinoline synthesis based on visible-light-
mediated photoredox catalysis has been developed and can be categorized as the following sections.65 
2.3.1. From iminyl or imidoyl radicals 
 
Among N-centered radicals in photoredox catalysis, iminyl and imidoyl radicals are usually 
involved in the synthesis of N-heterocycles. They are prepared from distinct methods with particular 
precursors such as N-acyl oximes, vinyl azide and isocyanides. In situ generated such radicals 
participate in the formation of quinoline under visible light irradiation. 
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In 2015, Zhang and co-workers developed a method for generation of iminyl radical from N-
acyl oxime. Intramolecular homolytic aromatic substitution (HAS) was achieved by utilization of the 
radical to form quinoline.66 In the same manner, Yu and co-workers developed the method to form 
quinoline through in situ generation of N-acyl oxime and generation of iminyl radical.67 (Scheme 2-1) 
 
Scheme 2-1. Cyclization of N-acyl oximes 
 
In the same year, Zhou and co-workers developed the synthesis of quinoline with vinyl azide 
and α-carbonyl benzyl bromide. Reduction of the bromide by the excited *[fac-Ir(ppy)3] results in a 
radical intermediate and addition of the intermediate into the vinyl azide produces the desired iminyl 
radical. Subsequently, intramolecular aromatic substitution is followed.68 (Scheme 2-2) 
 
Scheme 2-2. Cross-coupling between vinyl azide and bromide 
 
In 2018, Zhang and co-workers developed the synthesis of polycyclic quinoline by cross-
coupling and cyclization between isocyanoarenes and N-(alkyl-2-yn-1-yl)pyridine-2(1H)-one under 
visible-light-mediated photoredox catalysis. The uptake of an electron of N-(alkyl-2-yn-1-yl)pyridine-
2(1H)-one from reductively quenched [Ru(bpy)3]
+ produces a radical intermediate, releasing iodide 
anion. Radical addition to isocyano group yields the desired imidoyl radical and subsequent 




Scheme 2-3. Formation of imidoyl radical from isocyanides 
 
2.3.2. Dehydrogenation of tetrahydroquinolines 
 
Dehydrogenation of H-rich molecules requires quantitative amount of toxic oxidants. 
Therefore, removal of H atoms as H2 gas by acceptorless dehydrogenation is highly desired because H2 
gas is non-polluting, valuable energy fuel.  
In 2017, Li and co-workers developed dehydrogenation of tetrahydroquinolines combining 
photoredox catalysis with cobalt catalysis. The repetitive generation of H2 gas can be achieved by 
single-electron-transfer (SET) from the excited *[Ru(bpy)3]
2+ and uptake of protons from 
intermediates.70 (Scheme 2-4) 
 
Scheme 2-4. Dehydrogenation in dual photoredox/cobalt catalysis 
 
2.3.3. Povarov cyclization 
 
Povarov reaction is a type of [4 + 2] cycloaddition between imines and alkenes, also named 
aza-Diels-alder reaction, yielding tetrahydroquinoline.71 The Povarov reaction along with 
dehydrogenation (aromatization to quinoline) usually requires the use of oxidizing agents including 
metals or quantitative amount of DDQ or peroxides. Employment of photoredox catalysis enables to 
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produce imine from radical cation of the electron-rich amines. Then, [4 + 2] cycloaddition between the 
imine and alkenes in intra/intermolecular manner followed by dehydrogenation results in the formation 
of quinoline in the way of simpler and cleaner way. 
In 2016, Zhang and co-workers developed the intramolecular Povarov reaction mediated by 
visible-light-induced photoredox catalysis. The excited *[Ru(bpy)3]
2+ oxidizes the amine to its radical 
cation, then imine formation is achieved by hydrogen atom abstraction by superoxide radical anion. 
Lewis acid-assisted intramolecular cyclization, followed by aromatization produces the desired 
quinoline.72 (Scheme 2-5) 
 
Scheme 2-5. Intramolecular Povarov reaction by photoredox catalysis 
In the same year, Li and co-workers developed the intermolecular version of Povarov reaction 
through coupling between glycine esters and alkenes. The oxidation of glycine is achieved by oxidation 
of the excited *[Ru(bpy)3]
2+
 then imine is formed under aerobic condition. The formed imine is not only 
stabilized but also activated by Cu salt.73 (Scheme 2-6.) 
 
Scheme 2-6. Intermolecular Povarov reaction by photoredox catalysis 
In 2018, Zhang and co-workers developed metal-free visible-light-mediated Povarov reaction, 
which involves coupling between glycine esters and 2,3-dihydrofurans. Instead of metallic 
photocatalyst, the generation of key intermediate, imine, was achieved by employment of Eosin Y. The 
resulted quinoline-fused lactone was obtained through intramolecular ester exchange.74 (Scheme 2-7)  
 
Scheme 2-7. Intermolecular Povarov reaction by Eosin Y 
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2.3.4. N-Propargyl aniline/imine 
 
N-Propargyl amines are widely used in the synthesis of important N-heterocyclic compounds 
such as pyridine, pyrrole, 1,4-diazepane and so on.75 They have been also utilized to the synthesis of 
highly substituted quinoline via cyclization and aromatization. Especially, the synthesis in photoredox 
catalysis usually begins with radical addition of in situ generated nucleophilic radicals on the alkyne. 
Then, the resulted vinyl radical participates in the cyclization, followed by aromatization. 
 
In 2018, Zhou and co-workers initially developed the synthesis of quinoline from N-propargyl 
amine. The quinoline was formed by condensation between alkynyl imine and alkene and cascade 
radical additions. The presence of gem-difluorinated ring is characteristic. Due to the electronegativity 
and lipophilicity, exchange of proton with fluorine is important in drug design.76 (Scheme 2-8) 
 
Scheme 2-8. Synthesis of gem-difluorinated quinoline 
 
In the same year, Liu and co-workers developed the synthesis of quinoline possessing 
fluorinated substituents from N-propargyl amines. Again, radical addition of in situ generated radicals 
from bromodifluoroacetate or bromofluoroacetate is followed by cyclization to neighboring aromatic 
ring. Bromodifluoroacetate and bromofluoroacetate are often employed as inexpensive fluorine source 
for coupling.77 (Scheme 2-9) 
 




2.3.5. Aniline derivatives 
 
Anilines have been widely employed as building blocks for construction of N-heterocyclic 
compounds. Also, aniline and its derivatives were explored in photo-catalyzed synthesis of quinolines. 
The following examples commonly go through the formation of imine/enamine intermediates from 
anilines, then subsequent oxidation by photocatalyst enables intramolecular radical cyclization. 
In 2016, Zhang and co-workers developed the synthesis of 2-arylquinoline from the coupling 
between aromatic ketones and 2-aminobenzylamine. Condensation between ketone and aniline results 
in the formation of amino-imine, which is oxidized by the excited *[Ru(bpy)3]
2+. The oxidized radical 
cation is further oxidized by superoxide ion then followed hydrolysis produces aldehyde-imine. 
Intramolecular cyclization and elimination of resulted alcohol form 2-arylquinolines.78 (Scheme 2-10) 
 
Scheme 2-10. Synthesis of 2-arylquinoline 
 
In 2017, Xia and co-workers developed the synthesis of 4-carbonyl-quinolines and quinoline-
2,3-dicarboxylate via oxidative intramolecular/intermolecular cyclization with photoredox catalysts in 
the presence of oxygen.79 
Initially, the intramolecular version of photo-oxidative cyclization was achieved with ortho-
alkynyl enamine The organic photocatalyst, Mes-Acr-Me+ is irradiated by visible light, then oxidizes 
the enamine to form its radical cation intermediate. The resonance form of the radical cation, which is 
stabilized by the presence of electron-withdrawing group, participates in radical cyclization, followed 
by deprotonative O-O cleavage supported by copper to produce 4-carbonyl-quinoline (Scheme 2-11) 
 
Scheme 2-11. Intramolecular synthesis of 4-carbonyl-quinoline 
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The concept of oxidative radical cyclization was also tolerated with the intermolecular version 
between ortho-alkynyl aniline and dimethyl acetylenedicarboxylate. The Michael-addition product also 
gets oxidized by the excited *[Ru(bpy)3]
2+ and follows the same mechanism. (Scheme 2-12) 
 
Scheme 2-12. Intermolecular synthesis of 4-carbonyl-quinoline 
 
Intermolecular addition/radical cyclization strategy was extended to o-alkenyl aniline in the 
presence of palladium. The addition of amine into the activated alkyne is mediated by palladium, then 
photo-oxidative radical cyclization is followed. Instead of O-O cleavage in the version of o-alkynyl 
aniline, oxidative C-C cleavage affords quinoline-2,3-dicarboxylates. (Scheme 2-13) 
 
Scheme 2-13. Intermolecular synthesis of quinoline-2,3-dicarboxylate 
Even though all the developments of synthesis of quinoline in photoredox catalysis are useful 








Chapter 3. Three-Component Synthesis of 
Quinolines based on Radical Cascade 
Visible-light Photoredox Catalysis 
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3.1. Design of synthesis of quinoline 
 
Due to their utilities, significant efforts have been made to develop efficient synthetic methods 
for quinolines. Conventional synthesis including Miller, Skraup, Friedländer, Combes, Pfitzinger, and 
Conrad-Limpach reactions typically relies on condensation under harsh conditions and often leads to 
poor regioselectivity. In order to overcome these limitations, transition metal-catalyzed reactions, 
iodine-mediated reactions as well as visible-light photoredox reactions have been developed. 
In this report, we wish to describe quinoline synthesis based on radical cascade three-
component reaction catalyzed by visible-light photoredox catalysis. We envisioned that coordination of 
the chemoselectivity among reactants may be feasible by the differential electronic properties of radical 
sources and acceptors such that the tandem cyclization of the three coupling partners smoothly proceeds 
in order (Scheme 3-1). Thus, we reasoned that the combination of electron-rich β-aminoacrylates with 
electron-deficient halides and alkenes as the reactants would meet the requirement. Detailed 
mechanistic studies led us to propose an unexpected reaction mechanism. 
 





3.2. Reaction optimization for synthesis of quinoline 
 
 
Scheme 3-2. Photoredox catalysts used in Table 3-1. 












1 1 2 Ru(bpy)3(PF6)2 (2) NaHCO3 (2) MeCN (0.2) 18 Trace 
2 1 2 Eosin Y (2) NaHCO3 (2) MeCN (0.2) 18 14% 
3 1 2 Ru(phen)3Cl2 (2) NaHCO3 (2) MeCN (0.2) 18 20% 
4 1 2 Ir(ppy)3 (2) NaHCO3 (2) MeCN (0.2) 18 45% 
5 1 2 Ir(dF(CF3)ppy)2(dtbbpy)PF6 (2) NaHCO3 (2) MeCN (0.2) 18 47% 
6 1 2 Ir(ppy)2(dtbbpy)PF6 (2) NaHCO3 (2) MeCN (0.2) 18 58% 
7 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) MeCN (0.2) 18 66% 
8 1.5 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (3) MeCN (0.2) 18 45% 
9 2 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (3) MeCN (0.2) 18 40% 
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10 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) Acetone (0.2) 18 63% 
11 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) DMF (0.2) 18 65% 
12 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) DCM (0.2) 18 38% 
13 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) CHCl3 (0.2) 18 45% 
14 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) 1,2-DCE (0.2) 18 31% 
15 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) EtOAc (0.2) 18 38% 
16 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) THF (0.2) 18 36% 
17 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) DMSO (0.2) 18 Trace 
18 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) NMP (0.2) 18 Trace 
19 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) MeOH(0.2) 18 Trace 
20 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) PhH (0.2) 18 Trace 
21 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) MeCN (0.4) 18 43% 
22 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) MeCN (0.1) 18 73% 
23 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaHCO3 (2) MeCN (0.05) 18 76% 
24 1 3 Ir(ppy)2(dtbbpy)PF6 (3) KHCO3 (2) MeCN (0.05) 18 76% 
25 1 3 Ir(ppy)2(dtbbpy)PF6 (3) Na2HPO4 (2) MeCN (0.05) 18 78% 
26 1 3 Ir(ppy)2(dtbbpy)PF6 (3) K2HPO4 (2) MeCN (0.05) 18 72% 
27 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaH2PO4(2) MeCN (0.05) 18 43% 
28 1 3 Ir(ppy)2(dtbbpy)PF6 (3) KH2PO4 (2) MeCN (0.05) 18 33% 
29 1 3 Ir(ppy)2(dtbbpy)PF6 (3) NaOAc (2) MeCN (0.05) 18 71% 
30 1 3 Ir(ppy)2(dtbbpy)PF6 (3) KOAc (2) MeCN (0.05) 18 Trace 
31 1 3 Ir(ppy)2(dtbbpy)PF6 (3) Na3PO4 (2) MeCN (0.05) 18 73% 
32 1 3 Ir(ppy)2(dtbbpy)PF6 (3) K3PO4 (2) MeCN (0.05) 18 Trace 
33 1 3 Ir(ppy)2(dtbbpy)PF6 (3) Cs2CO3 (2) MeCN (0.05) 18 Trace 
34 1 3 Ir(ppy)2(dtbbpy)PF6 (3) CsOAc (2) MeCN (0.05) 18 Trace 
35 1 3 Ir(ppy)2(dtbbpy)PF6 (3) CsF (2) MeCN (0.05) 18 Trace 
36 1 3 Ir(ppy)2(dtbbpy)PF6 (3) DBU (2) MeCN (0.05) 18 Trace 
37 1 3 Ir(ppy)2(dtbbpy)PF6 (3) DABCO (2) MeCN (0.05) 18 Trace 
38 1 3 Ir(ppy)2(dtbbpy)PF6 (3) Na2HPO4 (1) MeCN (0.05) 18 81% 
39 1 3 Ir(ppy)2(dtbbpy)PF6 (3) Na2HPO4 (3) MeCN (0.05) 18 79% 
a Reactions were conducted under argon atmosphere with 0.05 mmol scale. 




Our initial attempts commenced with the reaction of β-aminoacrylate 1a (1 equiv.) with 
diethyl bromomalonate 2a (1 equiv.) and N-methyl maleimide 3a (2 equiv.) in MeCN (0.2 M) in the 
presence of NaHCO3 (2 equiv.) under blue irradiation of blue light from LED stripe at room 
temperature. Upon completion of the reaction under visible light, teterhydroquinoline intermediate 
was directly oxidized to quinoline 4a with with 2,3- Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). 
All yields in Table 3-1 were calculated based on 1H NMR spectroscopic analysis in the presence of 
stoichiometric amount of 1,1,2-trichloroethene as an internal standard.  
We started the optimization with the survey of various photoredox catalysts. The use of 
Ru(bpy)3(PF6)2 gave a trace amount of the three-component coupling product 4a (Entry 1). While an 
improved but low yield (20%) of 4a was obtained with Ru(phen)3Cl2 (Entry 3), iridium-based 
complexes provided more promising results with Ir(ppy)2(dtbbpy)PF6 giving a highest yield (58%) 
among other iridium-based complexes (Entries 4~6). On the other hand, organic dye Eosin Y turned 
out to be much less effective than the iridium catalysts (Entry 2). To examine the influence of catalyst 
loading and the equivalence of alkene 3a on the efficiency of the reaction, increased amounts of 
Ir(ppy)2(dtbbpy)PF6 (3 mol%) and 3a (3 equiv.) were employed, which resulted in a slightly improved 
yield (66%) (Entry 7). In contrast, the increased amount of radical source 2a led to diminished yields; 
1.5 equiv. and 2 equiv. gave 45% and 40%, respectively (Entries 8, 9).  
Next, we observed the significant solvent effects when a variety of solvents were tested. 
Acetonitrile, acetone and DMF gave comparable yields (68%, 65%, and 63%, respectively) (Entries 7, 
10, 11), while other chlorinated solvents, EtOAc and THF gave quinoline 4a in moderate yields 
(Entries 12~16). Interestingly, trace amounts of quinoline 4a were obtained when other polar solvents 
(DMSO, NMP and MeOH) were employed (Entries 17~19). Also, the use of nonpolar solvent such as 
benzene afforded a poor result (Entry 20). Since the reaction involves tandem intermolecular reaction 
followed by intramolecular cyclization, we anticipated that reaction concentration would play an 
important role. It turned out that high reaction concentration (0.4 M) is detrimental to the reaction 
efficiency as yield decreased to 43% as opposed to 66% with 0.2 M concentration. (Entry 21). On the 
contrary to this, dilution of reaction mixture to lower concentration (0.1 M and 0.05 M) gave the 
improved yields (73% and 76%, respectively) (Entries 22 and 23). 
With the optimal reaction concentration identified, we became intrigued by the effect of 
base. It appeared that no such counter ion effect was observed for bases including bicarbonate, mono 
and dibasic phosphates, affording comparable yields with both sodium and potassium cations 
(NaHCO3 vs. KHCO3, 76% vs. 76%; Na2HPO4 vs. K2HPO4, 78% vs. 72%; NaH2PO4 vs. KH2PO4, 
43% vs. 33%) (Entries 23~28). On the other hand, for certain inorganic bases including acetates and 
34 
 
phosphates, counter cations have the crucial impact for the efficient transformation (NaOAc vs. 
KOAc, 71% vs. trace; Na3PO4 vs. K3PO4, 73% vs. trace) (Entries 29~32). None of cesium salts 
(Cs2CO3, CsOAc, and CsF) and amine bases (DBU and DABCO) gave the coupling product (Entries 
33-37). Finally, the equivalence of base could be reduced without affecting the reaction efficiency 
(Entry 38 vs Entries 25 and 39). 
 
3.3. Preliminary result 
 
Table 3-2. Preliminary result with optimized reaction condition in Table 3-1. a, b 
 
a Reaction conditions: 1 (0.1 mmol), 2a (0.1 mmol), 3a (0.3 mmol), Ir(ppy)2(dtbbpy)PF6 (3 mol%), Na2HPO4 (0.1 mmol), 
MeCN (0.05 M), DDQ (0.21 mmol), toluene (0.1 M). 
b isolated yield.  
With the optimized conditions in hand, we turned our attention to the scope of this reaction, 
in which various β-aminoacrylates 1 have been investigated for their reactivity in this three-
component reaction. However, the reaction conditions turned out to be unsatisfactory in that β-
aminoacrylates 1 containing functionalized aryl groups such as 1d, 1j and 1l gave poor to moderate 




In this stage, we mechanistically propose that oxidative quenching of the excited 
photocatalyst Ir(III)* by a single electron transfer (SET) process to electron-deficient bromide 2a 
initiates the reaction by the generation of the corresponding electrophilic radical 2a’, which reacts 
with electron-rich β-aminoacrylate 1a to give α-amino radical I. Subsequent intercept of the 
nucleophilic α-amino radical I by electron-deficient alkene 3a leads to the formation of another 
electron-deficient radical species III, which undergoes annulation by addition to the aryl group of III. 
Finally, oxidation of aryl radical intermediate IV by the photocatalyst affords tetrahydroquinoline VI. 
Formation of quinoline 4a is achieved by one-pot oxidation of the tetrahydroquinoline with DDQ 
(Scheme 3-3). 
 




3.4. Second reaction optimization 
 
 
Scheme 3-4. Photoredox catalysts used in Table 3-3 



















1 1 3 Ru(phen)3Cl2 (3) NaAsc (2) Na2HPO4 (1) Acetone (0.05) 18 17 
2 1 3 Ru(bpy)3(PF6)2 (3) NaAsc (2) Na2HPO4 (1) Acetone (0.05) 18 30 
3 1 3 
Ir[dF(CF3)ppy]2 
(dtbbpy)PF6 (3) 
NaAsc (2) Na2HPO4 (1) Acetone (0.05) 18 67 
4 1 3 
Ir(ppy)2(dtbbpy) 
PF6 (3) 
NaAsc (2) Na2HPO4 (1) Acetone (0.05) 18 75 
5 1 3 fac-Ir(ppy)3 (3) NaAsc (2) Na2HPO4 (1) Acetone (0.05) 18 77 
6 1 3 Eosin Y (3) NaAsc (2) Na2HPO4 (1) Acetone (0.05) 18 38 
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7 1 3 Rose Bengal (3) NaAsc (2) Na2HPO4 (1) Acetone (0.05) 18 33 
8 1 3 Ir(ppy)3 (3) DIPEA (2) Na2HPO4 (1) Acetone (0.05) 18 19 
9 1 3 Ir(ppy)3 (3) iPr2NH (2) Na2HPO4 (1) Acetone (0.05) 18 18 
10 1 3 Ir(ppy)3 (3) 
(4-MeO-Ph) 
Ph2N (2) 
Na2HPO4 (1) Acetone (0.05) 18 74 
11 1 3 Ir(ppy)3 (3) DABCO (2) Na2HPO4 (1) Acetone (0.05) 18 Trace 
12 1 3 Ir(ppy)3 (3) 
Hantzsch 
ester (2) 
Na2HPO4 (1) Acetone (0.05) 18 17 
13 1 3 Ir(ppy)3 (3) 
Ascorbic  
acid (2) 
Na2HPO4 (1) Acetone (0.05) 18 63 
14 1.2 3 Ir(ppy)3 (3) NaAsc (2) 
Na2HPO4 
(1.2) 
Acetone (0.05) 18 84 
15 1.5 3 Ir(ppy)3 (3) NaAsc (2) Na2HPO4 (1.5) Acetone (0.05) 18 75 
16 2 3 Ir(ppy)3 (3) NaAsc (2) Na2HPO4 (2) Acetone (0.05) 18 71 
17 1.2 2 Ir(ppy)3 (3) NaAsc (2) Na2HPO4 (1.2) Acetone (0.05) 18 69 
18 1.2 4 Ir(ppy)3 (3) NaAsc (2) Na2HPO4 (1.2) Acetone (0.05) 18 81 
19 1.2 3 Ir(ppy)3 (3) NaAsc (2) NaOAc (1.2) Acetone (0.05) 18 31 
20 1.2 3 Ir(ppy)3 (3) NaAsc (2) KOAc (1.2) Acetone (0.05) 18 trace 
21 1.2 3 Ir(ppy)3 (3) NaAsc (2) NaHCO3 (1.2) Acetone (0.05) 18 80 
22 1.2 3 Ir(ppy)3 (3) NaAsc (2) KHCO3 (1.2) Acetone (0.05) 18 50 
23 1.2 3 Ir(ppy)3 (3) NaAsc (2) K2HPO4 (1.2) Acetone (0.05) 18 72 
24 1.2 3 Ir(ppy)3 (3) NaAsc (2) Na2CO3 (1.2) Acetone (0.05) 18 59 
25 1.2 3 Ir(ppy)3 (3) NaAsc (2) Cs2CO3 (1.2) Acetone (0.05) 18 trace 
26 1.2 3 Ir(ppy)3 (3) NaAsc (2) DBU (1.2) Acetone (0.05) 18 trace 
27 1.2 3 Ir(ppy)3 (3) NaAsc (2) Na2HPO4 (1.2) MeCN (0.05) 18 74 
28 1.2 3 Ir(ppy)3 (3) NaAsc (2) Na2HPO4 (1.2) DMF (0.05) 18 49 
29 1.2 3 Ir(ppy)3 (3) NaAsc (2) Na2HPO4 (1.2) DMSO (0.05) 18 19 
30 1.2 3 Ir(ppy)3 (3) NaAsc (2) Na2HPO4(1.2) CH2Cl2 (0.05) 18 trace 
31 1.2 3 Ir(ppy)3 (3) NaAsc (2) Na2HPO4 (1.2) CHCl3 (0.05) 18 41 
32 1.2 3 Ir(ppy)3 (3) NaAsc (2) Na2HPO4 (1.2) EtOAc (0.05) 18 trace 
33 1.2 3 Ir(ppy)3 (3) NaAsc (2) Na2HPO4 (1.2) MeOH (0.05) 18 trace 
34 1.2 3 - NaAsc (2) Na2HPO4 (1.2) Acetone (0.05) 18 trace 
35 1.2 3 
Ir(ppy)3 (3)  
<dark> 
NaAsc (2) Na2HPO4 (1.2) Acetone (0.05) 18 trace 
a Reactions were conducted under argon atmosphere with 0.05 mmol scale. 




We envisaged that addition of an external electron donor may increase the efficiency of the 
catalytic cycle. The results on the combination of various catalysts and reducing agents are 
summarized in Table 3-3.  
By employing 1d as a benchmark along with sodium ascorbate (NaAsc) as an external 
electron donor, we surveyed various photoredox catalysts. 4d was obtained in poor yields after in-situ 
oxidation of the tetrahydroquinoline when ruthenium-based catalysts including Ru(phen)3Cl2 and 
Ru(bpy)3(PF6)2 were used (Entries 1 and 2; 17%, and 30%, respectively). Iridium-based complexes 
provided more promising results with fac-Ir(ppy)3 giving an improved yield (77%, Entry 5). On the 
other hand, organic dyes including Eosin Y and Rose Bengal turned out to be inferior to iridium 
catalysts (Entries 6 and 7).  
Next, with fac-Ir(ppy)3 as an optimal photocatalyst, we examined the effects of various 
electron donors. Alkyl amines including diisopropylethylamine (DIPEA) (Ep/2
ox = + 0.65 V vs SCE in 
MeCN at 25 °C)80 and diisoproylamine (Ep/2
ox = + 1.09 V vs SCE in MeCN at 25 °C)81 gave low 
yields (19% and 18%, respectively) (Entries 8 and 9), while 74% of quinoline 4d was obtained when 
4-methoxy-N,N-diphenylaniline (Ep/2
ox = + 0.82 V vs Ag/AgCl in MeCN at 25 °C, see experimental 
data) was employed (Entry 10). Widely used electron donors including DABCO (Ep/2
ox = + 0.69 V vs 
SCE in MeCN at 25 °C)82 and Hantzsch ester (Ep/2
ox = + 0.72 V vs SCE in MeCN at 25 °C)83 proved 
to be ineffective (trace and 17%, Entries 11 and 12, respectively). Replacement of NaAsc (Ep/2
ox = + 
0.33 V vs Ag/AgCl in MeCN at 25 °C)84 to ascorbic acid resulted in a decrease in yield (77% to 63%, 
Entries 5 and 13, respectively).  
With NaAsc as the optimized electron donor in hand, the stoichiometric control of reactants 
(radical source 2a and coupling partner 3a) was followed. The minor increase of 2a (1.2 equiv.) along 
with the equal amount of base (1.2 equiv.) leaded the improvement of yield up to 84% (Entry 14), 
while further increase of both showed the tendency of decrease in yield (75% and 71%, Entries 15 and 
16, respectively). Plus, the reduced amount of 3a to 2 equiv. and increased amount of 3a to 4 equiv. 
was not effective, indicating 3 equiv. of 3a was the optimal amount (Entries 17 and 18).   
The detailed investigation on bases and solvents was conducted in the same manner of Table 3-1, 
indicating that the use of Na2HPO4 (1.2 equiv.) was still helpful, while the optimal solvent was 
changed from acetonitrile to acetone (Entries 19~33). Finally, control experiments performed in the 
absence of either catalyst or visible light showed no product formation, which supported that the 
reaction is indeed mediated by visible light photoredox catalysis (entries 34 and 35). 
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3.5. Substrate scope in β-aminoacrylate 
 
Table 3-4. Substrate scope in β-aminoacrylate 1 a, b 
 
a Reaction conditions: 1 (0.1 mmol), 2a (0.12 mmol), 3a (0.3 mmol), fac-Ir(ppy)3 (3 mol%), sodium ascorbate (0.2 mmol), 
Na2HPO4 (0.12 mmol), acetone (0.05 M) then, 2,3- Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (0.41 mmol), toluene 
(0.1 M). 
b All isolated yield. 




With the newly optimized conditions in hand, we turned our attention to the scope of the 
developed reaction, in which various β-aminoacrylates 1 have been investigated for their reactivity in 
this three-component coupling (Table 3-4).  
We began by examining the influence of various substituents on the aromatic ring on the 
reaction. Substitution with a methyl group on the para or ortho position was tolerated to afford the 
corresponding quinolines 4b and 4c after oxidation with DDQ. Even though one of the two positions 
available in annulation step was blocked by the ortho-methyl group, substitution on ortho position did 
not affect the formation of quinolines 4c. We also examined the tolerability of different halides under 
the reaction condition and found that iodo, bromo, and chloro- substituted quinolines 4d, 4e, 4f could 
be prepared in good yields. The reaction with the substrates bearing electron-donating groups such as 
methoxy group proceeded smoothly to give 4g and 4h, while that with a free hydroxy group gave the 
corresponding quinoline 4i in a moderate yield. Aminoquinolines 4j and 4k were successfully 
synthesized by employing substrates containing Boc-protected amine 1j and 1k. Also, that bearing 
electron-deficient aryl group 1l gave the corresponding quinoline 4l in moderate yield. β-
aminoacrylate 1m containing a bulky tert-butyl ester, instead of methyl ester, successfully participated 




3.6. Substrate scope in C-C unsaturated bonds and halides 
3.6.1. Substrate scope in maleimide 
 
Table 3-5. Substrate scope in maleimide 3 a, b 
 
a Reaction conditions: 1a (0.1 mmol), 2a (0.12 mmol), 3 (0.3 mmol), fac-Ir(ppy)3 (3 mol%), sodium ascorbate (0.2 mmol), 
Na2HPO4 (0.12 mmol), acetone (0.05 M) then, 2,3- Dichloro-5,6-dicyano-1,4-benzoquinone (0.41 mmol), toluene (0.1 M). 
b All isolated yield. 
Next, we examined the effect of substituents on maleimide 3 (Table 3-5). The use of 
maleimides with N-alkyl groups including methyl, benzyl and cyclohexyl groups provided the 
corresponding quinolines 4a, 4n and 4o in good yields. While the maleimide lacking a N-substituent 3p 
furnished 4p in moderate yield (56%), TBDMS-protected maleimide 3q provided the corresponding 
quinoline 4q along with the deprotected quinoline 4p in 68% yield (almost 1:1).  
42 
 
In order to investigate electronic effects, maleimides 3r, 3s and 3t bearing aryl groups with different 
electronic properties were subjected to the reaction. Whereas phenyl substituted 3r and electron-rich 3s 
respectively provided quinoline 4r and 4s in similar yields, the use of the maleimide bearing an electron-
deficient aryl group 3t resulted in relatively lower yield (63%). We also examined the compatibility of 
maleimide containing N-alkoxy group, which is known to be labile under photoredox conditions.85 
Gratifyingly, 3u with a benzyloxy group gave 4u in 78% yield. With the anticipation of bis-quinoline 
formation, we employed [1,1'-bipyrrole]-2,2',5,5'-tetraone 3v as a coupling partner, however, it gave 
only mono-annulated product 4v in 55% yield. Interestingly, when 4v was re-subjected to the reaction 
as a coupling partner, the second annulation did not proceed. 
3.6.2. Substrate scope in activated unsaturated C-C bonds 
 
Table 3-6. Substrate scope in activated unsaturated bond a, b 
 
a Reaction conditions: 1g (0.1 mmol), 2a (0.12 mmol), 3 (0.3 mmol), fac-Ir(ppy)3 (3 mol%), sodium ascorbate (0.2 mmol), 
Na2HPO4 (0.12 mmol), acetone (0.05 M) then, 2,3- Dichloro-5,6-dicyano-1,4-benzoquinone (0.41 mmol), toluene (0.1 M). 
b All isolated yield. 




In addition to maleimides, we turned our attention to the scope of unsaturated carbon-carbon 
bonds, which are activated by neighboring electron-withdrawing groups (Table 3-6). Fumaronitrile 
3w, which is highly electron-deficient, turned out to be a good coupling partner affording quinoline 
4w in 71% yield. While a moderate yield of 4x and 4x’ was obtained with 2:1 ratio when less 
activated 1,2-cyanoacrylate 3x was employed, no product corresponding to 4y formed when diethyl 
fumarate 3y was used. 
 
Scheme 3-5. Radical addition to activated alkene 
We rationalized these results based on the electrophilicity of alkenes 3, as radical acceptors 
toward nucleophilic radical intermediates I at the annulation step. The electrophilicity of alkenes was 
deduced from their relative redox potentials. The redox potentials were measured by cyclic 
voltammetry. (Ep/2
red of 3w = - 1.22 V vs Ag/AgCl in MeCN at 25 °C, Ep/2
red of 3x = - 1.29 V vs 
Ag/AgCl in MeCN at 25 °C and Ep/2
red of 3y = - 1.40 V vs Ag/AgCl in MeCN at 25 °C, Figure 3-1).  
   
  
Figure 3-1. Reduction potentials of activated alkenes 3w, 3x and 3y 
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Fumaronitrile, 3w
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(E)-ethyl 3-cyanoacrylate, 3x




The higher the relative reduction potential of alkene is, the more it is readily to accept an 
electron. Therefore, fumaronitrile 3w showed the highest yield among alkenes because of its highest 
reduction potential indicating strong electrophilicity, whereas no product was observed with fumarate 
3y. Plus, the ratio of 4x and 4x’ can be explained by the location of radical and the stability of radical 
at intermediate III. We also examined the reactivity of alkyne vs. alkene by employing (E)-dimethyl 
hex-2-en-4-ynedioate 3z as a coupling partner, and found that the reaction proceeds selectively on the 
alkyne to give 4z in moderate yield. 
 
3.6.3. Substrate scope with Perfluorinated substituents 
 
Table 3-7. Substrate scope with fluorinated substituents a, b 
 
a Reaction conditions: 1g (0.1 mmol), 2a (0.2 mmol), 3 (0.3 mmol), fac-Ir(ppy)3 (3 mol%), sodium ascorbate (0.2 mmol), 
Na2HPO4 (0.2 mmol), acetone (0.05 M) then, 2,3- Dichloro-5,6-dicyano-1,4-benzoquinone (0.41 mmol), toluene (0.1 M). 
b All isolated yield. 
Given that fluorination is an important tactic to modulate the physicochemical properties of 
drugs, we have shown that perfluorinated substituents can be readily introduced by using the 
corresponding coupling partners. Thus, quinolines 4aa and 4ab with fluorinated substituents were 
prepared in good yields by using n-heptafluoropropyl iodide 2aa and Togni’s reagent II 2ab, 




3.7. Mechanistic studies 
3.7.1. Control experiments 
 
In order to probe the reaction mechanism, we have performed several experiments described 
in this section. 
 
Scheme 3-6. Control experiments (1) 
 During the survey of substrate scope, the formation of isomeric mixture of enamine 5a was 
often observed as by-products, which led us to examine the intermediacy of 5a in the course of 
reaction. In place of radical mechanism, the incorporation of maleimide 3a may proceed through 
Diels-Alder reaction after tautomerization to intermediate A. However, this could be ruled out based 
on the observation that desired tetrahydroquinoline B did not form when enamine 5a and maleimide 
3a were subjected to the standard reaction conditions (Scheme 3-6). In other words, the possibility of 
intermediacy of 5a could be excluded. 
 
Scheme 3-7. Control experiments (2) 
This led us to the postulation that successful coupling of 5b and 3a under photoredox 
conditions would provide an evidence for the intermediacy of α-amino radical C derived from 5b (Eq. 
1, Scheme 3-7). An initial attempt by using fac-Ir(ppy)3 as a catalyst failed to give C, which is 
consistent with the result from a fluorescence quenching experiment and redox potentials; 5b (Ep/2
ox = 
+ 0.98 V vs Ag/AgCl in MeCN at 25 °C, Figure 3-2) vs. fac-Ir(ppy)3 (E
III*/II = + 0.31 V vs SCE in 
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MeCN at 25 °C). In terms of oxidation potentials, the excited fac-Ir(ppy)3 has insufficient oxidative 
potential for oxidation of 5b to produce α-amino radical C (Figure 3-3). In other words, the 
coincidence between the normalized intensity of the solution containing only photocatalyst (Blue, 
Figure 3-3) and that of the solution containing both photocatalyst and 5b (orange, Figure 3-3) proved 




 = + 0.98 V  
(vs SCE in MeCN at 25°C) 
 
Figure 3-2. Measurement of oxidation potential of 5b 
 
Figure 3-3. Fluorescence quenching between 5b and fac-Ir(ppy)3 
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Meanwhile, as the oxidation potential of 5b was known by measurement of cyclic 
voltammetry, Ir[dF(CF3)ppy]2(dtbbpy)PF6 was chosen because of its higher oxidation potential (E
III*/II 
= + 1.21 V vs SCE in MeCN at 25 °C). So, we were able to observe the clear interaction between 
photocatalyst and 5b in fluorescence quenching study, when Ir[dF(CF3)ppy]2(dtbbpy)PF6 was 
employed instead of fac-Ir(ppy)3 (Figure 3-4). Again, the blue line indicated the normalized intensity 
of the solution containing the photocatalyst only and orange line showed that of the solution 
containing both photocatalyst and 5b. The fully diminished graph in orange proved that the excited 
photocatalyst was readily quenched by 5b through redox interaction. Therefore, replacement of 
photocatalyst from fac-Ir(ppy)3 to Ir[dF(CF3)ppy]2(dtbbpy)PF6 enabled to oxidize 5b to produce α-
amino radical C, forming the isomeric mixture of D in 43 % yield. The characterization of the 
isomeric mixture in D was confirmed based on HRMS analysis due to the complexity of isomers in 
NMR. These results strongly suggest the coupling of maleimide 3a proceeds via radical mechanism.86, 
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Next, we turned our attention to the mechanism, tracing the origin of radical species by 
employing 2,2,6,6-Tetramethylpiperidin-1-yl)oxyl, TEMPO, which is widely used as a radical 
scavenger.  
 
Scheme 3-8. Control experiments (3) 
 In the absence of maleimide 3a, reaction between β-aminoacrylate 1a and bromomalonate 2a 
under standard condition produced the isomeric mixture of enamine 5a in 99 % yield (Eq. 1, Scheme 
3-8). Meanwhile, when 2 equimolar amount of TEMPO was injected, the formation of enamine 5a was 
completely suppressed and a large amount of malonate-TEMPO adduct E was obtained in 97 % after 
isolation (Eq. 2, Scheme 3-8). This is consistent with the hypothesis that the generation of malonyl 
radical 2a’ proceeds through oxidative quenching of photoexcited [IrIII]*. 
 
 
Scheme 3-9. Control experiments (4) 
 On the other hand, when the reaction of 1a and 2a was performed in the presence of 3a and 
TEMPO, the maleimide-TEMPO adduct F, which was unstable for isolation, was observed by HRMS 
along with 4a and E (trace and 30% isolated yield, respectively) (Scheme 3-9). We were perplexed by 




3.7.2. Fluorescence quenching study 
 
Our initial mechanistic hypothesis was that the excited [IrIII]* would undergo oxidative 
quenching by 2a to give 2a’, however, the presence of 3a’ prompted us to investigate the competitive 




 = - 1.42 V  
(vs SCE in MeCN at 25°C) 
 
Figure 3-5. Measurement of reduction potential of 2a 
In order to identify the radical species forming first in the catalytic cycle, Stern-Volmer 
quenching studies were performed. The redox potential of fac-Ir(ppy)3 (E
III*/IV = - 1.73 V vs SCE in 
MeCN at 25 °C) indicates that oxidative quenching of [IrIII]* by both 2a and 3a would be feasible 
(Ep/2
2a/2a•- = - 1.42 V vs Ag/AgCl in MeCN at 25 °C, Figure 3-5 and Ep/2
3a/3a•- = - 1.21 V vs SCE in 
MeCN at 25 °C,88 respectively). Fluorescence quenching study of 2a and 3a with phased concentrations 
was independently conducted with a fixed amount of fac-Ir(ppy)3 (Figure 3-6). In the case of both 2a 
and 3a, the normalized intensity of excited fac-Ir(ppy)3 was inversely proportional to the concentration 
of 2a or 3a, indicating that they did participate in the quenching of the excited fac-Ir(ppy)3 in the redox 
interaction. Then, this result was converted into Stern-Volmer plot for the direct comparison about the 
preference of quenching between 2a and 3a. Based on the slope of each trend curve, the Stern-Volmer 
plot clearly suggested that 3a was the preferred electron acceptor over 2a. 





Figure 3-6. Fluorescence quenching study of 2a (left) and 3a (right) with fac-Ir(ppy)3 
 
Figure 3-7. Comparison of Stern-Volmer Plots of 2a and 3a 
  
This result of the preferential reduction of 3a over 2a raises the question of identification of 
the counterpart reacting with radical anion 3a’ derived from 3a. We speculated that the radical anion 
3a’ is responsible for the reduction of 2a to 2a’. Therefore, additional fluorescence quenching 

























































y = 0.2165x + 1

















Figure 3-8. Fluorescence quenching study of mixture of 2a and 3a 
 To our surprise, much greater extent of fluorescence quenching was observed in comparison 
to those taken separately (Expanded graph, blue and grey, Figure 3-8). Again, the increase of 
concentration of mixture also leaded stronger quenching of the photocatalyst. This synergistic effect 
could be reasoned that the reversible quenching of the excited [IrIII]* in the presence of 3a alone 
becomes irreversible when both 3a and 2a are present, in which 2a is irreversibly reduced to 2a’ by 
3a’. This result could also account for the presence of the radical species derived from 3a evidenced 
by 3a-TEMPO adduct F (Scheme 3-10). 
 























Emission Wavelength (nm) 


































3.7.3. Visible-light on/off experiment 
 
We have performed an experiment with light-on/off to investigate whether the reaction 
involves radical chain propagation. However, this could be ruled out as the conversion comes to a halt 
as shown in Figure 3-9. The recorded yields were determined by 1H NMR spectroscopy with the 
addition of trichloroethylene as an internal standard. 
 






3.7.4. Plausible Mechanism 
 Based on the mechanistic studies, we propose a plausible mechanism shown in Scheme 3-11. 
The reaction is initiated with oxidative quenching of the excited [IrIII]* by 3a to form radical anion 3a’, 
which allows the reduction of 2a resulting in the formation of malonyl radical 2a’. Selective coupling 
of the electron-deficient radical 2a’ with electron-rich β-aminoacrylate 1a over electron-deficient alkene 
3a leads to the formation of α-amino radical species I. Concomitant redox reaction of I and 3a catalyzed 
by the catalyst provides iminium species II and radical anion 3a’, which undergoes coupling to afford 
radical species III. Subsequently, intramolecular cyclization of the resulting electron-deficient radical 
III with the electron-rich aryl group furnishes IV, which proceeds to form tetrahydroquinoline VI by 
oxidation followed by aromatization. Lastly, one pot oxidation with DDQ provides quinoline 4. 
 
Scheme 3-11. Plausible Mechanism 
 In sum, we have developed an efficient three-component radical cascade reaction for the 
synthesis of highly substituted quinolines based on visible-light photoredox catalysis. This method, 
which involves three consecutive radical-mediated bond formations, allows chemoselective 




3.8. Experimental procedures and data 
 
3.8.1. General methods 
 
All the reactions were carried out in oven dried glassware under nitrogen atmosphere with 
freshly distilled dry solvents under anhydrous conditions unless otherwise indicated. Solvents for the 
key step and optimization table are dried by drying agents (appropriate for each solvent, for example, 
acetonitrile was distilled from P2O5) and distilled out. Then they were degassed by bubbling of nitrogen 
gas for 30 minutes with cooling bath. All key step reactions were set under nitrogen atmosphere in 
glovebox. Organic solutions were concentrated under reduced pressure on a Büchi rotary evaporator 
using water bath. Analytical thin layer chromatography (TLC) was performed using Merck TLC Silica 
gel 60 F254 precoated plate (0.2 mm thickness). After elution, plates were visualized using UV radiation 
(254 nm) on Spectroline Model ENF-240C/FE 254 nm. Further visualization was possible by staining 
with basic solution of potassium permanganate or acidic solution of ceric molybdate. Flash column 
chromatography was performed with Silica Flash P60 silica gel (230-400 mesh). All reagents were 
obtained from commercial sources (Alfa Aesar, Sigma Aldrich, TCI Chemicals) and were used without 
further purification. 
Proton (1H) and carbon (13C) NMR spectra were recorded on a 400/100 MHz Agilent 400M 
FT-NMR spectrometer or 400/100 MHz Bruker Advance III FT-NMR spectrometer. NMR solvents 
were obtained from Cambridge Isotope Laboratories and the residual solvent signals were taken as the 
reference (0.0 ppm for 1H NMR spectra and 77.0 ppm for 13C NMR spectra in CDCl3). The signals 
observed are described as: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet). Coupling 
constants are reported as J value in Hz. High resolution mass analysis (HRMS) was performed with 
Bruker HCT Basic System coupled with Agilent 1200 Series. Cyclic voltammetry spectra were recorded 
on WizMAC WizECM – 1200 Premium. Luminescence quenching studies were performed with Varian 
Cary Eclipse. The reaction mixture of key steps was irradiated with a 12 W blue LED lamp (5 cm away, 
25 °C maintained with a cooling fan). For reactions irradiated by microwave, Biotage Initiator+ was 
used. Systematic nomenclature for the compounds follows the numbering system as defined by IUPAC 




3.8.2. Synthetic procedures for β-aminoacrylates 
 
3.8.2.1. General procedure A (for 1a ~ 1l) 
 
 
 To a solution of aniline (1 equiv.) in MeOH (1 M) was added methyl propiolate (1.1 equiv.). 
The reaction was stirred and irradiated in microwave synthesizer for 30 minutes at 80 °C. Upon 
completion (monitored by TLC analysis), the solution was concentrated under reduced pressure. The 
residue was purified by flash chromatography. 
Methyl 3-(phenylamino)acrylate (1a): Prepared according to General Procedure A from aniline and 
methyl propiolate. Yield 70%. 
 
1H NMR (400 MHz, CDCl3): δ 9.87 (d, 1H, J = 10.4 Hz) δ 7.28 – 7.21 (m, 3H) δ 7.00 – 6.94 (m, 3H) 
δ 4.83 (d, 1H, J = 8.4 Hz) δ 3.70 (s, 3H). NMR data is consistent with the reported data. 
 
Methyl 3-(p-tolylamino)acrylate (1b): Prepared according to General Procedure A from p-toluidine 
and methyl propiolate. Yield 57% 
 
1H NMR (400 MHz, CDCl3): δ 9.82 (d, 1H, J = 12.0 Hz) δ 7.22 (dd, 1H, J = 8.3 Hz, 12.8 Hz) δ 7.10 
(d, 2H, J = 8.0 Hz) δ 6.87 (d, 2H, J = 7.8 Hz) δ 4.81 (d, 1H, J = 8.3 Hz) δ 3.72 (s, 3H) δ 2.30 (s, 3H). 
NMR data is consistent with the reported data. 
 
Methyl 3-(o-tolylamino)acrylate (1c): Prepared according to General Procedure A from o-toluidine 




1H NMR (400 MHz, CDCl3): δ 10.0 (d, 1H, J = 11.4 Hz) δ 7.32 (dd, 1H, J = 8.3 Hz, 12.5 Hz) δ 7.19 
(m, 2H) δ 7.04 (d, 1H, J = 7.9 Hz) δ 6.94 (m, 1H) δ 4.89 (d, 1H, J = 8.2 Hz) δ 3.74 (s, 3H) δ 2.34 (s, 
3H) NMR data is consistent with the reported data. 
 
Methyl 3-((4-iodophenyl)amino)acrylate (1d): Prepared according to General Procedure A from 4-
iodo aniline and methyl propiolate. Yield 57%. 
 
1H NMR (400 MHz, CDCl3): δ 9.87 (d, 1H, J = 12.7 Hz) δ 7.58 (d, 2H, J = 8.8 Hz) δ 7.18 (dd, 1H, J = 
8.4 Hz, 12.6 Hz) δ 6.73 (d, 2H, J = 8.8 Hz) δ 4.89 (d, 1H, J = 8.4 Hz) δ 3.72 (s, 3H) NMR data is 
consistent with the reported data. 
 
methyl 3-((4-bromophenyl)amino)acrylate (1e): Prepared according to General Procedure A from 
4-bromo aniline and methyl propiolate. Yield 60%. 
 
1H NMR (400 MHz, CDCl3): δ 9.88 (d, 1H, J = 12.3 Hz) δ 7.40 (d, 2H, J = 8.9 Hz) δ 7.18 (dd, 1H, J = 
8.4 Hz, 12.3 Hz) δ 6.84 (d, 2H, J = 8.9 Hz) δ 4.88 (d, 1H, J = 8.4 Hz) δ 3.72 (s, 3H) NMR data is 
consistent with the reported data. 
 
Methyl 3-((4-chlorophenyl)amino)acrylate (1f): Prepared according to General Procedure A from 
4-chloro aniline and methyl propiolate. Yield 40% 
 
1H NMR (400 MHz, CDCl3): δ 9.88 (d, 1H, J = 11.4 Hz) δ 7.26 (d, 2H, J = 8.8 Hz) δ 7.17 (dd, 1H, J = 
12.6 Hz, 8.4 Hz)) δ 6.89 (d, 2H, J = 8.8 Hz) δ 4.88 (d, 1H, J = 8.4 Hz) δ 3.72 (s, 3H) NMR data is 
consistent with the reported data. 
 
Methyl 3-((4-methoxyphenyl)amino)acrylate (1g): Prepared according to General Procedure A 





1H NMR (400 MHz, CDCl3): δ 9.79 (d, 1H, J = 13.6 Hz) δ 7.15 (dd, 1H, J = 8.25 Hz, 12.84 Hz) δ 
6.92 (d, 2H, J = 9.02 Hz) δ 6.85 (d, 2H, J = 9.02 Hz) δ 4.79 (d, 1H, J = 8.25 Hz) δ 3.78 (s, 3H) δ 3.71 
(s, 3H). NMR data is consistent with the reported data. 
 
Methyl 3-((2-methoxyphenyl)amino)acrylate (1h): Prepared according to General Procedure A 
from 2-methoxyaniline and methyl propiolate. Yield 66% 
 
1H NMR (400 MHz, CDCl3): δ 10.14 (d, 1H, J = 11.9 Hz) δ 7.28 (dd, 1H, J = 8.3 Hz, 13.1 Hz) δ 7.03 
(dd, 1H, J = 1.8 Hz, 7.4 Hz) δ 6.93 (dqd, 3H, J = 1.8 Hz, 7.4 Hz, 14.9 Hz) δ 4.88 (d, 1H, J = 8.3 Hz) δ 
3.92 (s, 3H) δ 3.73 (s, 3H). NMR data is consistent with the reported data. 
 
Methyl 3-((4-hydroxyphenyl)amino)acrylate (1i): Prepared according to General Procedure A from 
4-hydroxyaniline and methyl propiolate. Yield 60% 
 
1H NMR (400 MHz, CDCl3): δ 9.75 (d, 1H, J = 11.1 Hz) δ 7.14 (dd, 1H, J = 8.3 Hz, 12.8 Hz) δ 6.86 
(d, 2H, J = 8.9 Hz) δ 6.79 (d, 2H, J = 8.9 Hz) δ 4.78 (d, 1H, J = 8.2 Hz) δ 3.71 (s, 3H). MS (ESI) m/z 
calcd. for C10H11NO3 ([M+H]
+ ) 194.07, found 194.1. 
 
Methyl 3-((4-((tert-butoxycarbonyl)amino)phenyl)amino)acrylate (1j): Prepared according to 





1H NMR (400 MHz, CDCl3): δ 9.82 (d, 1H, J = 12.6 Hz) δ 7.29 (d, 2H, J = 8.7 Hz) δ 7.18 (dd, 1H, J = 
8.3 Hz, 12.6 Hz) δ 6.90 (m, 2H) δ 6.38 (br s, 1H) δ 4.81 (d, 1H, J = 8.3 Hz) δ 3.71 (s, 3H) δ 1.51 (s, 
9H). MS (ESI) m/z calcd. for C15H21N2O4 ([M+H]
+ ) 293.15, found 293.2 
 
Methyl 3-((2-((tert-butoxycarbonyl)amino)phenyl)amino)acrylate (1k): Prepared according to 
General Procedure A from tert-butyl (2-aminophenyl)carbamate and methyl propiolate. Yield 44%. 
 
1H NMR (400 MHz, CDCl3): δ 9.86 (d, 1H, J = 12.0 Hz) δ 7.47 (d, 1H, J = 7.8 Hz) δ 7.10 (m, 4H) δ 
6.26 (br s, 1H) δ 4.89 (d, 1H, J = 8.3 Hz) δ 3.71 (s, 3H) δ 1.53 (s, 9H). MS (ESI) m/z calcd. for 
C15H21N2O4 ([M+H]
+ ) 293.15, found 293.2 
 
Methyl 4-((3-methoxy-3-oxoprop-1-en-1-yl)amino)benzoate (1l): Prepared according to General 
Procedure A from methyl 4-aminobenzoate and methyl propiolate. Yield 42%. 
 
1H NMR (400 MHz, CDCl3): δ 10.07 (d, 1H, J = 12.5 Hz) δ 7.98 (d, 2H, J = 8.8 Hz) δ 7.29 (dd, 1H, J 
= 8.4 Hz, 12.5 Hz) δ 6.97 (d, 2H, J = 8.8 Hz) δ 4.96 (d, 1H, J = 8.4 Hz) δ 3.88 (s, 3H) δ 3.73 (s, 3H). 
NMR data is consistent with the reported data. 
 
3.8.2.2. General procedure B (for 1m) 
 
 
To a solution of aniline (3 equiv.), tert-butyl acrylate (1 equiv.), Pd(OAc)2 (3 mol%) and 
pivalic acid (0.25 equiv.) in NMP (2 M) was stirred for 15 hours at 60 °C under oxygen atmosphere. 
The solution was diluted with EtOAc and filtered through Celite. The solution was concentrated under 




tert-butyl 3-(phenylamino)acrylate (1m): Prepared according to General Procedure B from aniline 
and tert-butyl acrylate. Yield = 40%. 
 
1H NMR (400 MHz, CDCl3): δ 9.84 (d, 1H, J = 12.8 Hz) δ 7.31 – 7.27 (m, 2H) δ 7.18 (dd, 1H, J = 8.4 
Hz, 12.8 Hz) δ 7.01 – 6.92 (m, 3H) δ 4.75 (d, 1H, J = 8.4 Hz) δ 1.51 (s, 9H) MS (ESI) m/z calcd. for 
C13H18NO2 ([M+H]
+ ) 220.1, found 220.2. 
 
3.8.3. Synthetic procedures for maleimide 
 
3.8.3.1. General Procedure C (for 3n, 3o, 3r, 3s and 3t) 
 
 
To a solution of maleic anhydride (1 equiv.) in anhydrous toluene (0.2 M) was added amine 
(1 equiv.) in anhydrous toluene dropwise while stirring at room temperature. The solution was stirred 
for 2 hours at room temperature, the precipitate was filtered and washed with diethyl ether several 
time. The collected precipitate was dried under reduced pressure and used without further purification. 
To a solution of maleic acid (1 equiv.) in acetic anhydride (0.2 M) was added sodium acetate (1.2 
equiv.) and the solution was stirred at 120 °C overnight. The mixture was concentrated under reduced 
pressure and purified by flash chromatography on silica gel. 
 
1-benzyl-1H-pyrrole-2,5-dione (3n): Prepared according to General Procedure C from benzyl amine 
and maleic anhydride. Two-step yield 56%.  
 
1H NMR (400 MHz, CDCl3): δ 7.31 (m, 5H) δ 6.71 (s, 2H) δ 4.68 (s, 2H). NMR data is consistent 
with the reported data. 
 
1-cyclohexyl-1H-pyrrole-2,5-dione (3o): Prepared according to General Procedure C from 




1H NMR (400 MHz, CDCl3): δ 6.62 (s, 2H) δ 3.91 (tt,1H, J = 3.93 Hz, 12.43 Hz) δ 2.05 (qd, 2H, J = 
3.20 Hz, 12.43 Hz) δ 1.83 (d, 2H, J = 13.38 Hz) δ 1.66 (dd, 3H, J = 2.7, J = 12.2 Hz) δ 1.37 – 1.19 (m, 
3H). NMR data is consistent with the reported data. 
 
1-phenyl-1H-pyrrole-2,5-dione (3r): Prepared according to the General Procedure C from aniline 
and maleic anhydride. Two-step Yield 57%. 
 
1H NMR (400 MHz, CDCl3): δ 7.47 (t, 2H, J = 7.7 Hz) δ 7.36 (m, 3H) δ 6.85 (s, 2H). NMR data is 
consistent with the reported data. 
 
1-(4-methoxyphenyl)-1H-pyrrole-2,5-dione (3s): Prepared according to the General Procedure C 
from 4-methoxyaniline and maleic anhydride. Two-step Yield 59%. 
 
1H NMR (400 MHz, CDCl3): δ 7.23 (d, J = 9.1 Hz, 2H), δ 6.98 (d, J = 9.1 Hz, 1H), δ 6.83 (s, 2H), δ 
3.83 (s, 3H) NMR data is consistent with the reported data. 
 
methyl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate (3t): Prepared according to the General 
Procedure C from methyl 4-aminobenzoate and maleic anhydride. Two-step Yield 69% 
 
1H NMR (400 MHz, CDCl3): δ 8.14 (d, 2H, J = 8.8 Hz) δ 7.50 (d, 2H, J = 8.8 Hz) δ 6.89 (s, 2H) δ 
3.94 (s, 3H). NMR data is consistent with the reported data. 
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3.8.3.2. General procedure D (for 3q) 
 
 
To a stirred and cooled mixture of maleimide (1 equiv.) and TBDMS-Cl (1.1 equiv.) in DCM 
(0.2 M) was slowly added triethylamine (1.1 equiv.). The solution was refluxed and stirred overnight. 
The precipitated triethylammonium chloride was filtered and the filtrate was washed successively 
with 5% HCl solution, H2O and brine. The organic layer was dried (Na2SO4), filtered and 
concentrated under reduced pressure. The crude material was purified by flash chromatography. 
 
1-(tert-butyldimethylsilyl)-1H-pyrrole-2,5-dione (3q): Prepared according to the General 
Procedure D from maleimide. Yield 67% 
 
1H NMR (400 MHz, CDCl3): δ 6.67 (s, 2H), δ 0.93 (s, 9H), δ 0.44 (s, 6H). NMR data is 
consistent with the reported data. 
 
3.8.3.3. General procedure E (for 3u) 
 
 
Step 1: To a solution of maleic anhydride (1 equiv.) in anhydrous diethyl ether (0.5 M) was added 
furan (4 equiv.) while stirring at room temperature. The reaction was stirred for 24 hours at room 
temperature. The product was precipitated out and was collected by vacuum filtration. The colorless 






1H NMR (400 MHz, CDCl3): δ 6.58 (s, 2H), δ 5.46 (s, 2H), δ 3.18 (s, 2H), NMR data is consistent 
with the reported data. 
 
Step 2: To a solution of (3aR,4R,7S,7aS)-3a,4,7,7a-tetrahydro-4,7-epoxyisobenzofuran-1,3-dione (1 
equiv.) in anhydrous benzene (0.25 M) was added solution of N-benzyloxyamine (1 equiv.) in 
benzene while stirring at room temperature. The reaction was stirred and refluxed for 3 hours. After 
completion (monitored by TLC analysis), the solution was cooled and concentrated under reduced 




1H NMR (400 MHz, CDCl3): δ 7.48 (m, 2H), δ 7.37 (m, 3H), δ 6.49 (s, 2H), δ 5.25 (s, 2H) δ 5.07 (s, 
2H) δ 2.72 (s, 2H). MS (ESI) m/z calcd. for C15H14NO4 ([M+H]
+ ) 272.09, found 272.2 
 
 
Step 3: (3aR,4R,7S,7aS)-2-(benzyloxy)-3a,4,7,7a-tetrahydro-1H-4,7-epoxyisoindole-1,3(2H)-dione 
(1 equiv.) was heated in an oil bath at 170-180 °C under reduced pressure. The solid slowly melted 
with vigorous furan evolution. After completion of furan evolution (monitored by TLC analysis), the 







1H NMR (400 MHz, CDCl3): δ 7.48 (m, 2H), δ 7.38 (m, 3H), δ 6.58 (s, 2H), δ 5.10 (s, 2H). MS (ESI) 
m/z calcd. for C11H10NO3 ([M+H]
+ ) 204.6, found 204.8 
 
3.8.3.4. General procedure F (for 3v) 
 
 
Step 1: To a solution of (3aR,4R,7S,7aS)-3a,4,7,7a-tetrahydro-4,7-epoxyisobenzofuran-1,3-dione (1 
equiv.) in glacial acetic acid (1 M) was added hydrazine hydrate (0.5 equiv.) dropwise while stirring 
at RT. The reaction was stirred at RT for 1 hour and 50-60 °C for 1 hour then at RT for overnight. The 
product was precipitated out and was collected by vacuum filtration. The colorless precipitation was 





1H NMR (400 MHz, CDCl3): δ 6.55 (s, 4H), δ 5.39 (s, 4H), δ 3.00 (s, 4H). NMR data is consistent 
with the reported data. 
 
Step 2: (4R,4'R,5R,5'R,8S,8'S,9S,9'S)-4,5,8,8',9,9'-hexahydro-[2,2'-bi(4,7-epoxyisoindole)]-
1,1',3,3'(4'H,5'H)-tetraone (1 equiv.) was heated in an oil bath at 170-180 °C under reduced pressure. 
The solid slowly melted with vigorous furan evolution. After completion of furan evolution 







1H NMR (400 MHz, CDCl3): δ 6.93 (s, 4H). NMR data is consistent with the reported data. 
 
3.8.4. Synthetic procedures for other coupling partners 
 
3.8.4.1. (Z)-ethyl 3-cyanoacrylate (3x) 
 
 
Step 1: A solution of maleic anhydride (1 equiv.) in anhydrous 1,4-dioxane (0.2 M) was preheated to 
80 °C. When the maleic anhydride had melted, ammonium hydroxide solution was heated to 40 °C to 
generate ammonia gas. The stream of ammonia gas was introduced to the maleic anhydride solution 




1H NMR (400 MHz, MeOH-d4): δ 6.31 (d, 2H, J = 12.9 Hz), δ 6.05 (d, 2H, J = 12.9 Hz). MS (ESI) 
m/z calcd. for C4H6NO3 ([M+H]
+ ) 116.03, found 116.1 
 
 
Step 2: To a solution of (Z)-4-amino-4-oxobut-2-enoic acid (1 equiv.) in anhydrous CH2Cl2 (0.25 M) 
was cooled to 0 °C under nitrogen atmosphere. To the solution was added trimethylamine (2.05 
equiv.) dropwise followed by addition of ethyl chloroformate (2.2 equiv.) dropwise. After completion 
of addition, the solution was allowed to warm to RT and stirred for 24 h. After completion, a 10% 
aqueous NaOH solution was added to the reaction mixture and the organic layer was separated. The 
aqueous layer was extracted with dichloromethane three times and the combined organic layers was 
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dried over anhydrous MgSO4. The solution was concentrated under reduced pressure. The crude 
material was purified by flash chromatography. 
 
(Z)-ethyl 3-cyanoacrylate (3x): 
 
1H NMR (400 MHz, CDCl3): δ 6.57 (d, 2H, J = 11.5 Hz), δ 5.95 (d, 2H, J = 11.5 Hz), δ 4.33 (q, 2H, J 
= 7.1 Hz) δ 1.36 (t, 3H, J = 7.1 Hz). NMR data is consistent with the reported data. 
 
3.8.4.2. (E)-dimethyl hex-2-en-4-ynedioate (3z) 
 
 
To a solution of methyl propiolate (1 equiv.) in CH2Cl2 (0.5 M) at 0 °C was added DABCO (1 mol%) 
in CH2Cl2. The reaction immediately turned dark and was stirred for 1 hour. The solution was 
concentrated under reduced pressure. The crude material was purified by flash chromatography. 
 
(E)-dimethyl hex-2-en-4-ynedioate (3z) 
 
 
1H NMR (400 MHz, CDCl3): δ 6.79 (d, 2H, J = 16.0 Hz), δ 6.47 (d, 2H, J = 16.0 Hz), δ 3.83 (s, 3H), δ 




3.8.4.3. Togni’s reagent II (2ab) 
 
Step 1: To a solution of 2-iodobenzoic acid (1 equiv.) in MeCN (0.2 M) at 75 °C was added a 
solution of trichloroisocyanuric acid (1.01 Cl+ equiv.) in MeCN in one portion. The solution was 
stirred and heated at 75 °C for 30 minutes. After completion, the solution was diluted with MeCN and 
the precipitated product was filtered on vacuum filtration. The filter cake was rinsed with additional 







1H NMR (400 MHz, CDCl3): δ 8.26 (dd, 1H, J = 7.5, 1.5 Hz), δ 8.21 (d, 1H, J = 8.5 Hz), δ 8.00 (m, 
1H), δ 7.80 (t, 1H, J = 7.3 Hz). NMR data is consistent with the reported data. 
 
 
Step 2: To a solution of 1-chloro-1λ3 -benzo[d][1,2]iodaoxol-3(1H)-one (1 equiv.) in MeCN (1 M) 
was added potassium acetate (2 equiv.) under nitrogen atmosphere. The resulting suspension was 
stirred for 2 hours during refluxing. The solution was cooled to RT. and diluted with CHCl3 then 
filtered on Celite to remove KCl salt. The filtrate was concentrated under reduced pressure. The crude 







1H NMR (400 MHz, CDCl3): δ 8.27 (d, 1H, J = 7.6 Hz), δ 8.01 (d, 1H, J = 8.3 Hz), δ 7.93 (ddd, 1H, J 
= 8.3, 7.2, 1.6 Hz), δ 7.72 (t, 1H, J = 7.4 Hz). NMR data is consistent with the reported data. 
 
 
Step 3: To a solution of 1-acetoxy-1,2-benziodoxol-3-one (1 equiv.) in MeCN (0.5 M) was added 
anhydrous CsF (2.5 mol%), TMSCF3 (1.4 equiv.) under nitrogen atmosphere. The solution was stirred 
at RT for 24 hours (reaction turns brown). The white precipitation was collected by vacuum filtration. 
The white solid was dissolved in CHCl3 and insoluble materials were removed by filtration through a 
cotton plug. The colorless filtrate was washed with water and saturated Na2CO3 solution. The organic 
layer was dried over MgSO4, filtered and concentrated under reduced pressure to afford pure product.  
 
Togni’s reagent II (2ab) 
 
1H NMR (400 MHz, CDCl3): δ 8.48 (dd, 1H, J = 7.1, 1.9 Hz), δ 7.86 – 7.74 (m, 3H).  NMR 





3.8.5. Procedure for optimization studies 
 
3.8.5.1. First optimized reaction condition 
 
 
To an oven-dried 4 mL vial equipped with a stir bar was added photocatalyst Ir(ppy)2(dtbbpy)PF6 
(1.4 mg, 1.5 μmol, 0.03 equiv.), anhydrous sodium phosphate dibasic (powder) (7.1 mg, 0.05 mmol, 1 
equiv.), methyl 3-(phenyl amino) acrylate 1a (8.9 mg, 0.05 mmol, 1 equiv.) and N-methyl maleimide 
3a (16.7 mg, 0.15 mmol, 3 equiv.). Required amounts of anhydrous acetonitrile (1 mL) and diethyl 
bromomalonate 2a (90 % purity, 9.5 μL, 0.05 mmol, 1 equiv.) were added under argon atmosphere in 
glovebox. The reaction mixture was irradiated with a 12 W blue LED lamp (5 cm away, 25 °C 
maintained with a cooling fan) for 18 h. After evaporating the solvent under reduced pressure, the 
crude material was dissolved in toluene (1 mL) and treated with 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) (23.8 mg, 0.105 mmol, 2.1 equiv.). The mixture was heated at 100 °C for 2 h. 
NMR yields were calculated by using 1,1,2-trichloroethene as an internal standard. 
 





3.8.5.2. Second optimized reaction condition 
 
 
To an oven-dried 4 mL vial equipped with a stir bar was added photocatalyst fac-Ir(ppy)3 (1.0 mg, 1.5 
μmol, 0.03 equiv.), sodium ascorbate (19.8 mg, 0.1 mmol, 2 equiv.), anhydrous sodium phosphate 
dibasic (powder) (8.5 mg, 0.06 mmol, 1.2 equiv.), methyl 3-((4-iodophenyl) amino) acrylate 1d (15.2 
mg, 0.05 mmol, 1 equiv.) and N-methyl maleimide 3a (16.7 mg, 0.15 mmol, 3 equiv.). Required 
amounts of anhydrous acetone (1 mL) and diethyl bromomalonate 2a (90 % purity, 11.35 μL, 0.06 
mmol, 1.2 equiv.) were added under argon atmosphere in glovebox. The reaction mixture was irradiated 
with a 12 W blue LED lamp (5 cm away, 25 °C maintained with a cooling fan) for 18 h. After 
evaporating the solvent under reduced pressure, the crude material was dissolved in toluene (1 mL) and 
treated with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (46.5 mg, 0.205 mmol, 4.1 equiv.). 
The mixture was heated at 100 °C for 2 h. NMR yields were calculated by using 1,1,2-trichloroethene 
as an internal standard. 
 
3.8.6. Procedures for Three-Component Synthesis of Quinolines based on Radical Cascade Visible-
Light Photoredox Catalysis 
 
To an oven-dried 4 mL vial equipped with a stir bar was added photocatalyst fac-Ir(ppy)3 (2.0 
mg, 3 μmol, 0.03 equiv.), sodium ascorbate (39.6 mg, 0.2 mmol, 2 equiv.), anhydrous sodium 
phosphate dibasic (powder) (17 mg, 0.12 mmol, 1.2 equiv.), methyl 3-((4-iodophenyl) amino) acrylate 
1d (30.3 mg, 0.1 mmol, 1 equiv.) and N-methyl maleimide 3a (33.3 mg, 0.3 mmol, 3 equiv.). 
Required amounts of anhydrous acetone (2 mL) and diethyl bromomalonate 2a (90 % purity, 22.7 μL, 
0.12 mmol, 1.2 equiv.) were added under argon atmosphere in glovebox. The reaction mixture was 
irradiated with a 12 W blue LED lamp (5 cm away, 25 °C maintained with a cooling fan) for 18 h. 
After evaporating the solvent under reduced pressure, the crude material was dissolved in toluene (2 
mL) and treated with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (93 mg, 0.41 mmol, 4.1 
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equiv.). The mixture was heated at 100 °C for 2 h. Aromatization reaction was monitored by TLC 
analysis. The solution was filtered on Celite and concentrated under reduced pressure. The residue 
was purified by flash chromatography (silica gel, 20 – 50% EtOAc in hexanes), yielding the 
corresponding final product. 
 
3.8.7. Characterization data of Quinolines 4 
 
1,1-diethyl 2-methyl 2-(2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-yl) ethane-
1,1,2-tricarboxylate (4a): Prepared following the general procedure outlined above using methyl 3-
(phenyl amino) acrylate, 1a (17.7 mg, 0.1 mmol, 1 equiv.), diethyl bromomalonate 2a (90 % purity, 
22.7 μL, 0.12 mmol, 1.2 equiv.), N-methyl maleimide 3a (33.3 mg, 0.3 mmol, 3 equiv.), fac-Ir(ppy)3 
(2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), DDQ (93 
mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by column chromatography yielded the 




H NMR (400 MHz, CDCl3): δ 8.82 (d, 1H, J = 8.4 Hz) δ 8.10 (d, 1H, J = 8.6 Hz) δ 7.87 (t, 1H, J = 
7.73 Hz) δ 7.85 (t, 1H, J = 7.6 Hz) δ 5.81 (d, 1H, J = 9.75 Hz) δ 4.77 (d, 1H, J = 9.75 Hz) δ 4.32 (q, 
2H, J = 7.1 Hz) δ 4.02 (m, 2H) δ 3.65 (s, 3H) δ 3.25 (s, 3H) δ 1.35 (t, 3H, J = 7.12 Hz) δ 1.08 (t, 3H, J 
= 7.11 Hz). 
13
C NMR (100 MHz, CDCl3): δ 170.1, 168.1, 167.9, 167.7, 167.5, 151.6, 150.9, 136.4, 132.6, 129.8, 
129.6, 124.8, 122.5, 120.9, 61.8, 61.6, 52.8, 52.6, 48.1, 24.1, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C22H22N2NaO8 ([M+Na]
+) 465.1268, found 465.1269. 
 
1,1-diethyl 2-methyl 2-(2,8-dimethyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-yl) 
ethane-1,1,2-tricarboxylate (4b): Prepared following the general procedure outlined above using 
methyl 3-(p-tolyl amino) acrylate, 1b (19.1 mg, 0.1 mmol, 1 equiv.), diethyl bromomalonate 2a (90 % 
purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), N-methyl maleimide 3a (33.3 mg, 0.3 mmol, 3 equiv.), fac-
Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), 
DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by column chromatography 






H NMR (400 MHz, CDCl3): δ 8.58 (s, 1H) δ 7.98 (d, 1H, J = 8.7 Hz) δ 7.69 (dd, 1H, J = 1.9 Hz, 8.8 
Hz) δ 5.78 (d, 1H, J = 9.8 Hz) δ 4.75 (d, 1H, J = 9.8 Hz) δ 4.32 (qd, 2H, J = 0.9 Hz, 7.1 Hz) δ 4.01 (m, 
2H) δ 3.65 (s, 3H) δ 3.24 (s, 3H) δ 1.34 (t, 3H, J = 7.1 Hz) δ 1.06 (t, 3H, J = 7.1 Hz). 
13
C NMR (100 MHz, CDCl3): δ 170.2, 168.2, 167.9, 167.8, 167.5, 150.5, 149.8, 140.4, 135.4, 135.0, 
129.4, 123.3, 122.4, 121.1, 61.7, 61.6, 52.8, 52.6, 47.9, 24.0, 21.9, 14.0, 13.8; 
HRMS (ESI-TOF) m/z calcd. for C23H24N2NaO8 ([M+Na]+) 479.1425, found 479.1426. 
 
1,1-diethyl 2-methyl 2-(2,6-dimethyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-yl) 
ethane-1,1,2-tricarboxylate (4c): Prepared following the general procedure outlined above using 
methyl 3-(o-tolyl amino) acrylate, 1b (19.1 mg, 0.1 mmol, 1 equiv.), diethyl bromomalonate 2a (90 % 
purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), N-methyl maleimide 3a (33.3 mg, 0.3 mmol, 3 equiv.), fac-
Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), 
DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by column chromatography 




H NMR (400 MHz, CDCl3): δ 8.67 (d, 1H, J = 8.3 Hz) δ 7.70 (d, 1H, J = 7.0 Hz) δ 7.62 (m, 1H) δ 
5.75 (d, 1H, J = 9.3 Hz) δ 4.76 (d, 1H, J = 9.3 Hz) δ 4.31 (dddd, 2H, J = 3.6 Hz, 7.1 Hz, 10.8 Hz, 17.8 
Hz) δ 4.04 (dddd, 2H, J = 3.6 Hz, 7.1 Hz, 10.8 Hz, 17.8 Hz) δ 3.66 (s, 3H) δ 3.23 (s, 3H) δ 2.74 (s, 
3H) δ 1.33 (t, 3H, J = 7.1 Hz) δ 1.09 (t, 3H, J = 7.1 Hz);  
13
C NMR (100 MHz, CDCl3): δ 170.2, 168.1, 167.9, 167.8, 167.6, 149.99, 149.97, 138.1, 136.5, 
132.7, 129.6, 122.5, 122.3, 121.1, 61.8, 61.6, 52.7, 52.6, 48.5, 24.0, 18.1, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C23H24N2NaO8 ([M+Na]




1,1-diethyl 2-methyl 2-(8-iodo-2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-
yl)ethane-1,1,2-tricarboxylate (4d): Prepared following the general procedure outlined above using 
methyl 3-((4-iodophenyl) amino) acrylate, 1d (30.3 mg, 0.1 mmol, 1 equiv.), diethyl bromomalonate 
2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), N-methyl maleimide 3a (33.3 mg, 0.3 mmol, 3 
equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), 
acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by column 





H NMR (400 MHz, CDCl3): δ 9.20 (d, 1H, J = 1.80 Hz) δ 8.09 (dd, 1H, J = 2.0, 9.0 Hz) δ 7.79 (d, 
1H, J = 9.0 Hz) δ 5.77 (d, 1H, J = 9.8 Hz) δ 4.72 (d, 1H, J = 9.8 Hz) δ 4.31 (qd, 2H, J = 1.4 Hz, 7.1 
Hz) δ 4.01 (m, 2H) δ 3.64 (s, 3H) δ 3.24 (s, 3H) δ 1.33 (t, 3H, J = 7.14 Hz) δ 1.07 (t, 3H, J = 7.14 Hz). 
13
C NMR (100 MHz, CDCl3): δ 169.8, 167.7, 167.5, 167.4, 167.3, 152.3, 149.7, 141.4, 134.9, 133.6, 
131.0, 123.0, 122.2, 96.4, 61.8, 61.7, 52.7, 52.6, 48.0, 24.2, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C22H21IN2NaO8 ([M+Na]
+) 591.0235, found 591.0234. 
 
1,1-diethyl 2-methyl 2-(8-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-
yl)ethane-1,1,2-tricarboxylate (4e): Prepared following the general procedure outlined above using 
methyl 3-((4-bromophenyl) amino) acrylate, 1e (25.6 mg, 0.1 mmol, 1 equiv.),  diethyl 
bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), N-methyl maleimide 3a (33.3 mg, 
0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 
equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by 






H NMR (400 MHz, CDCl3): δ 8.99 (s, 1H) δ 7.94 (m, 2H) δ 5.78 (d, 1H, J = 9.76 Hz) δ 4.73 (d, 1H, 
J = 9.76 Hz) δ 4.32 (q, 2H, J = 6.7 Hz) δ 4.02 (m, 2H) δ 3.65 (s, 3H) δ 3.25 (s, 3H) δ 1.34 (t, 3H, J = 
7.12 Hz) δ 1.08 (t, 3H, J = 7.12 Hz). 
13
C NMR (100 MHz, CDCl3): δ 169.8, 167.8, 167.5, 167.4, 167.3, 152.1, 149.4, 136.2, 135.3, 131.2, 
129.1, 126.9, 124.5, 123.2, 121.8, 61.9, 61.7, 52.7, 48.0, 24.2, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C22H21BrN2NaO8 ([M+Na]
+) 543.0373, found 543.0376. 
 
1,1-diethyl 2-methyl 2-(8-chloro-2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-
yl) ethane-1,1,2-tricarboxylate (4f): Prepared following the general procedure outlined above using 
methyl 3-((4-chlorophenyl) amino) acrylate, 1f (21.2 mg, 0.1 mmol, 1 equiv.),  diethyl 
bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), N-methyl maleimide 3a (33.3 mg, 
0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 
equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by 




H NMR (400 MHz, CDCl3): δ 8.80 (d, 1H, J = 2.0 Hz) δ 8.03 (d, 1H, J = 9.2 Hz) δ 7.79 (dd, 1H, J = 
2.3 Hz, 9.2 Hz) δ 5.78 (d, 1H, J = 9.8 Hz) δ 4.73 (d, 1H, J = 9.8 Hz) δ 4.31 (q, 2H, J = 6.8) δ 4.02 (m, 
2H) δ 3.65 (s, 3H) δ 3.25 (s, 3H) δ 1.34 (t, 3H, J = 7.1 Hz) δ 1.08 (t, 3H, J = 7.1 Hz). 
13
C NMR (100 MHz, CDCl3): δ 169.9, 167.7, 167.5, 167.4, 167.3, 152.0, 149.2, 136.2, 135.5, 133.6, 
131.2, 129.6, 127.5, 123.6, 121.4, 61,8, 61.7, 52.7, 48.0, 24.2, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C22H21ClN2NaO8 ([M+Na]
+) 499.0879, found 499.0880. 
 
1,1-diethyl 2-methyl 2-(8-methoxy-2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-
yl)ethane-1,1,2-tricarboxylate (4g): Prepared following the general procedure outlined above using 
methyl 3-((4-methoxyphenyl) amino) acrylate, 1g (20.7 mg, 0.1 mmol, 1 equiv.),  diethyl 
bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), N-methyl maleimide 3a (33.3 mg, 
0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 
equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by 






H NMR (400 MHz, DMSO): δ 7.98 (d, 1H, J = 9.4 Hz) δ 7.96 (d, 1H, J = 2.8 Hz) δ 7.63 (dd, 1H, J 
= 2.9 Hz, 9.3 Hz) δ 5.58 (d, 1H, J = 9.8 Hz) δ 4.49 (d, 1H, J = 9.8 Hz) δ 4.21 (q, 2H, J = 7.1 Hz) δ 
3.94 (s, 3H) δ 3.89 (q, 2H, J = 7.1 Hz) δ 3.54 (s, 3H) δ 3.09 (s, 3H) δ 1.22 (t, 3H, J = 7.1 Hz) δ 0.87 (t, 
3H, J = 7.1 Hz). 
13
C NMR (100 MHz, DMSO): δ 170.0, 168.2, 168.0, 167.8, 167.1, 160.4, 148.3, 147.1, 134.7, 131.3, 
126.5, 122.9, 122.4, 101.7, 61.9, 61.8, 56.4, 53.02, 53.00, 47.6, 24.3, 14.3, 13.9. 
HRMS (ESI-TOF) m/z calcd. for C23H24N2NaO9 ([M+Na]
+) 495.1374, found 495.1375. 
 
1,1-diethyl 2-methyl 2-(6-methoxy-2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-
yl) ethane-1,1,2-tricarboxylate (4h): Prepared following the general procedure outlined above using 
methyl 3-((2-methoxyphenyl) amino) acrylate, 1h (20.7 mg, 0.1 mmol, 1 equiv.),  diethyl 
bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), N-methyl maleimide 3a (33.3 mg, 
0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 
equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by 




H NMR (400 MHz, CDCl3): δ 8.58 (s, 1H) δ 7.98 (d, 1H, J = 8.7 Hz) δ 7.69 (d, 1H, J = 8.8 Hz) δ 
5.78 (d, 1H, J = 9.8 Hz) δ 4.75 (d, 1H, J = 9.8 Hz) δ 4.31 (q, 2H, J = 7.1 Hz) δ 4.01 (m, 2H) δ 3.64 (s, 
3H) δ 3.24 (s, 3H) δ 2.60 (s, 3H) δ 1.34 (t, 3H, J = 7.1 Hz) δ 1.06 (t, 3H, J = 7.1 Hz). 
13
C NMR (100 MHz, CDCl3): δ 170.2, 168.2, 167.9, 167.8, 167.5, 150.5, 149.8, 140.4, 135.4, 135.0, 
129.4, 123.3, 122.4, 121.1, 61.7, 61.6, 52.8, 52.6, 47.9, 24.0, 21.9, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C23H24N2NaO9 ([M+Na]
+) 495.1374, found 495.1376. 
 
1,1-diethyl 2-methyl 2-(8-hydroxy-2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-
yl) ethane-1,1,2-tricarboxylate (4i): Prepared following the general procedure outlined above using 
75 
 
methyl 3-((4-hydroxyphenyl) amino) acrylate, 1i (19.3 mg, 0.1 mmol, 1 equiv.), diethyl 
bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), N-methyl maleimide 3a (33.3 mg, 
0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 
equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by 




H NMR (400 MHz, DMSO): δ 10.85 (s, 1H) δ 7.94 (dd, 2H, J = 6.1 Hz, 7.7 Hz) δ 7.52 (dd, 1H, J = 
2.7 Hz, 9.2 Hz) δ 5.56 (d, 1H, J = 9.9 Hz) δ 4.47 (d, 1H, J = 9.9 Hz) δ 4.21 (dd, 2H, J = 6.6 Hz, 13.7 
Hz) δ 3.88 (q, 2H, J = 7.0 Hz) δ 3.53 (s, 3H) δ 3.08 (s, 3H) δ 1.22 (t, 3H, J = 7.1 Hz) δ 0.86 (t, 3H, J = 
7.0 Hz) 
13
C NMR (100 MHz, DMSO): δ 170.19, 168.3, 168.1, 167.8, 167.1, 159.2, 147.2, 146.4, 134.1, 
131.5, 126.6, 122.7, 122.6, 104.8, 61.8, 61.7, 53.0, 52.9, 47.5, 24.3, 14.3, 13.9. 
HRMS (ESI-TOF) m/z calcd. for C22H22N2NaO9 ([M+Na]
+) 481.1218, found 481.1220. 
 
1,1-diethyl 2-methyl 2-(8-((tert-butoxycarbonyl)amino)-2-methyl-1,3-dioxo-2,3-dihydro-1H-
pyrrolo[3,4-c]quinolin-4-yl)ethane-1,1,2-tricarboxylate (4j): Prepared following the general 
procedure outlined above using methyl 3-((4-((tert-butoxycarbonyl)amino)phenyl)amino)acrylate, 1j 
(29.2 mg, 0.1 mmol, 1 equiv.), diethyl bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 
equiv.), N-methyl maleimide 3a (33.3 mg, 0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 
equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 




H NMR (400 MHz, CDCl3): δ 8.32 (d, 1H, J = 1.74 Hz) δ 8.17 (d, 1H, J = 8.8 Hz) δ 7.98 (d, 1H, J = 
9.3 Hz) δ 7.17 (s, 1H) δ 5.75 (d, 1H, J = 10.0 Hz) δ 4.76 (d, 1H, J = 10.0 Hz) δ 4.32 (m, 2H) δ 4.05 
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(m, 2H) δ 3.65 (s, 3H) δ 3.19 (s, 3H) δ 1.58 (s, 9H) δ 1.34 (t, 3H, J = 7.1 Hz) δ 1.09 (t, 3H, J = 7.1 
Hz). 
13
C NMR (100 MHz, CDCl3): δ 170.29, 167.93, 167.88, 167.74, 167.70, 152.27, 149.39, 147.87, 
139.94, 134.78, 130.68, 125.26, 122.84, 121.66, 109.56, 81.6, 61.79, 61.75, 52.86, 52.68, 47.95, 
28.26, 24.01, 14.06, 13.8 
HRMS (ESI-TOF) m/z calcd. for C27H31N3NaO10 ([M+Na]
+) 580.1902, found 580.1903. 
 
1,1-diethyl 2-methyl 2-(6-((tert-butoxycarbonyl)amino)-2-methyl-1,3-dioxo-2,3-dihydro-1H-
pyrrolo[3,4-c]quinolin-4-yl)ethane-1,1,2-tricarboxylate (4k): Prepared following the general 
procedure outlined above using methyl 3-((2-((tert-butoxycarbonyl)amino)phenyl)amino)acrylate, 1k 
(29.2 mg, 0.1 mmol, 1 equiv.), diethyl bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 
equiv.), N-methyl maleimide 3a (33.3 mg, 0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 
equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 





H NMR (400 MHz, CDCl3): δ 8.64 (d, 1H, J = 7.6 Hz) δ 8.60 (s, 1H) δ 8.40 (dd, 1H, J = 8.4, 11 Hz) 
δ 7.71 (t, 1H, J = 8.2 Hz) δ 5.72 (d, 1H, J = 8.6 Hz) δ 4.65 (d, 1H, J = 8.6 Hz) δ 4.32 (m, 2H) δ 4.10 
(m, 2H) δ 3.69 (s, 3H) δ 3.23 (s, 3H) δ 1.60 (s, 9H) δ 1.30 (t, 3H, J = 7.1 Hz) δ 1.13 (t, 3H, J = 7.1 Hz)  
13
C NMR (100 MHz, CDCl3): δ 169.94, 167.81, 167.69, 167.67, 167.54, 152.66, 149.19, 140.52, 
136.57, 135.82, 131.01, 123.19, 121.19, 118.00, 117.16, 81.16, 61.98, 61.85, 52.79, 52.58, 48.45, 
28.37, 24.18, 13.99, 13.84. 
HRMS (ESI-TOF) m/z calcd. for C27H31N3NaO10 ([M+Na]
+) 580.1902, found 580.1903. 
 
1,1-diethyl 2-methyl 2-(8-(methoxy carbonyl)-2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo [3,4-c] 
quinolin-4-yl) ethane-1,1,2-tricarboxylate (4l): Prepared following the general procedure outlined 
above using methyl 4-((3-methoxy-3-oxoprop-1-en-1-yl) amino) benzoate, 1l (19.3 mg, 0.1 mmol, 1 
equiv.), diethyl bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), N-methyl 
maleimide 3a (33.3 mg, 0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 
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(17 mg, 0.12 mmol, 1.2 equiv.), Acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 




H NMR (400 MHz, CDCl3): δ 8.87 (d, 1H, J = 8.7 Hz) δ 8.79 (d, 1H, J = 1.5 Hz) δ 8.31 (dd, 1H, J = 
1.5, 8.7 Hz) δ 5.81 (d, 1H, J = 9.7 Hz) δ 4.76 (d, 1H, J = 9.7 Hz) δ 4.33 (q, 2H, J = 7.1 Hz) δ 4.09-4.00 
(m, 5H) δ 3.66 (s, 3H) δ 3.26 (s, 3H) δ 1.36 (t, 3H, J = 7.1 Hz) δ 1.10 (t, 3H, J = 7.1 Hz). 
13
C NMR (100 MHz, CDCl3): δ 169.9, 167.8, 167.6, 167.5, 167.4, 166.0, 152.9, 150.4, 136.3, 133.6, 
131.9, 129.0, 125.2, 124.0, 123.2, 61.9, 61.8, 52.82, 52.80, 48.1, 24.2, 14.1, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C24H24N2NaO10 ([M+Na]
+) 523.1323, found 523.1325. 
 
2-tert-butyl 1,1-diethyl 2-(2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-yl) 
ethane-1,1,2-tricarboxylate (4m): Prepared following the general procedure outlined above using 
tert-butyl 3-(phenyl amino) acrylate, 1m (22 mg, 0.1 mmol, 1 equiv.),  diethyl bromomalonate 2a 
(90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), N-methyl maleimide 3a (33.3 mg, 0.3 mmol, 3 equiv.), 
fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 
mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by column 




H NMR (400 MHz, CDCl3): δ 8.80 (d, 1H, J = 8.4 Hz) δ 8.07 (d, 1H, J = 8.5 Hz) δ 7.85 (ddd, 1H, J 
= 1.4 Hz, 7.4 Hz, 8.5 Hz) δ 7.72 (m, 1H) δ 5.64 (d, 1H, J = 9.1 Hz) δ 4.66 (d, 1H, J = 9.1 Hz) δ 4.32 
(m, 2H) δ 4.04 (pd, J = 3.7 Hz, 6.9 Hz) δ 3.23 (s, 3H) δ 1.37 – 1.32 (m, 12H) δ 1.10 (t, 3H, J = 7.1 
Hz). 
13
C NMR (100 MHz, CDCl3): δ 168.4, 168.1, 167.9, 167.8, 167.7, 152.3, 150.8, 136.1, 134.1, 132.4, 
129.7, 124.8, 122.7, 120.8, 82.5, 61.59, 61.58, 52.6, 49.2, 27.7, 24.0, 14.1, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C25H28N2NaO8 ([M+Na]




1,1-diethyl 2-methyl 2-(2-benzyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-yl) ethane-
1,1,2-tricarboxylate (4n): Prepared following the general procedure outlined above using methyl 3-
(phenyl amino) acrylate, 1a (17.7 mg, 0.1 mmol, 1 equiv.),   diethyl bromomalonate 2a (90 % 
purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), N-benzyl maleimide 3n (56.2 mg, 0.3 mmol, 3 equiv.), fac-
Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), 
DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by column chromatography 




H NMR (400 MHz, CDCl3): δ 8.81 (dd, 1H, J = 0.7 Hz, 8.4 Hz) δ 8.09 (d, 1H, J = 8.5 Hz) δ 7.86 
(ddd, 1H, J = 1.4 Hz, 6.9 Hz, 8.5 Hz) δ 7.73 (ddd, 1H, J = 1.1 Hz, 7.0 Hz, 8.2 Hz) δ 7.47 (d, 2H, J = 
6.9 Hz) δ 7.39 – 7.28 (m, 3H) δ 5.79 (d, 1H, J = 9.7 Hz) δ 4.90 (d, 2H, J = 3.3 Hz) δ 4.73 (d, 1H, J = 
9.7 Hz) δ 4.32 (qd, 2H, J = 1.3 Hz, 7.1 Hz) δ 3.98 (qd, 2H, J = 2.2 Hz, 7.1 Hz) δ 3.63 (s, 3H) δ 1.34 (t, 
3H, J = 7.1 Hz) δ 1.03 (t, 3H, J = 7.1 Hz); 
13
C NMR (100 MHz, CDCl3): δ 170.0, 167.9, 167.6, 167.4, 167.3, 151.6, 151.0, 136.2, 135.9, 132.6, 
129.8, 129.7, 128.75, 128.71, 128.0, 124.8, 122.4, 121.0, 61.8, 61.6, 52.8, 52.6, 48.1, 41.8, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C28H26N2NaO8 ([M+Na]
+) 541.1581, found 541.1582. 
 
1,1-diethyl 2-methyl 2-(2-cyclohexyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-yl) 
ethane-1,1,2-tricarboxylate (4o): Prepared following the general procedure outlined above using 
methyl 3-(phenyl amino) acrylate, 1a (17.7 mg, 0.1 mmol, 1 equiv.),   diethyl bromomalonate 2a 
(90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), 1-cyclohexyl-1H-pyrrole-2,5-dione, 3o (53.8 mg, 0.3 
mmol, 3 equiv.),  fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 
equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by 






H NMR (400 MHz, CDCl3): δ 8.81 (d, 1H, J = 7.9) δ 8.08 (d, 1H, J = 8.6 Hz) δ 7.85 (ddd, 1H, J = 
1.3 Hz, 7.0 Hz, 8.5 Hz) δ 7.75 – 7.70 (m ,1H) δ 5.78 (d, 1H, J = 9.7 Hz) δ 4.74 (d, 1H, J = 9.7 Hz) δ 
4.31(qd, 2H, J = 1.9 Hz, 7.1 Hz) δ 4.20 – 4.12 (m, 1H) δ 4.01 (qd, 2H, J = 3.0 Hz, 7.1 Hz) δ 2.24 (ddd, 
2H, J = 8.7 Hz, 12.8 Hz, 16.7 Hz) δ 1.89 (d, 2H, J = 13.0 Hz) δ 1.79 (d, 2H, J = 11.3 Hz) δ 1.72 (d, 
1H, J = 12.1 Hz) δ 1.45 – 1.36 (m, 2H) δ 1.33 (t, 3H, J = 7.1 Hz) δ 1.07 (t, 3H, J = 7.1 Hz). 
13
C NMR (100 MHz, CDCl3): δ 170.1, 168.0, 167.9, 167.7, 167.5, 151.5, 150.9, 136.0, 132.4, 129.7, 
129.5, 124.8, 122.1, 121.0, 61.7, 61.6, 52.8, 52.6, 51.2, 48.0, 29.9, 29.8, 26.0, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C27H30N2NaO8 ([M+Na]
+) 533.1894, found 533.1896.  
 
1,1-diethyl 2-methyl 2-(1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-yl) ethane-1,1,2-
tricarboxylate (4p): Prepared following the general procedure outlined above using methyl 3-(phenyl 
amino) acrylate, 1a (17.7 mg, 0.1 mmol, 1 equiv.),   diethyl bromomalonate 2a (90 % purity, 22.7 
μL, 0.12 mmol, 1.2 equiv.), maleimide 3p (29.3 mg, 0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 
mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), DDQ (93 mg, 0.41 
mmol, 4.1 equiv.) and toluene (2 mL). Purification by column chromatography yielded the pure 




H NMR (400 MHz, CDCl3): δ 8.81 (ddd, 1H, J = 0.6 Hz, 1.4 Hz, 8.4 Hz) δ 8.14 – 8.10 (m, 1H) δ 
7.89 (ddd, 1H, 1.5 Hz, 6.9 Hz, 8.5 Hz) δ 7.76 (ddd, 1H, J = 1.2 Hz, 6.9 Hz, 8.2 Hz) δ 5.77 (d, 1H, J = 
9.7 Hz) δ 4.77 (d, 1H, J = 9.7 Hz) δ 4.33 (qd, 2H, J = 0.8 Hz, 7.1 Hz) δ 4.07 – 4.00 (m, 2H) δ 3.66 (s, 
3H) δ 1.35 (t, 3H, J = 7.1 Hz) δ 1.09 (t, 3H, J = 7.1 Hz) 
13
C NMR (100 MHz, CDCl3): δ 170.0, 167.9, 167.5, 167.4, 167.0, 152.0, 151.0, 136.6, 135.1, 132.8, 
129.9, 124.8, 122.9, 121.1, 61.8, 61.7, 52.8, 52.7, 48.1, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C21H20N2NaO8 ([M+Na]





c]quinolin-4-yl)ethane-1,1,2-tricarboxylate (4q): Prepared following the general procedure outlined 
above using methyl 3-(phenyl amino) acrylate, 1a (17.7 mg, 0.1 mmol, 1 equiv.), diethyl 
bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), 1-(tert-butyldimethylsilyl)-1H-
pyrrole-2,5-dione 3q (63.3 mg, 0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), 
Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and 




H NMR (400 MHz, CDCl3): δ 8.84 (ddd, J = 8.3, 1.3, 0.5 Hz, 1H), δ 8.10 (d, J = 8.2 Hz, 1H), δ 7.85 
(ddd, J = 8.5, 6.9, 1.5 Hz, 1H), δ 7.72 (ddd, J = 8.3, 6.9, 1.2 Hz, 1H), δ 5.77 (d, J = 9.5 Hz, 1H), δ 4.73 
(d, J = 9.5 Hz, 1H), δ 4.32 (q, J = 6.9 Hz, 1H), δ 4.04 (qq, J = 7.0, 3.7 Hz, 1H), δ 3.64 (s, 3H), δ 1.34 
(t, J = 7.1 Hz, 2H), δ 1.09 (t, J = 7.1 Hz, 2H), δ 1.01 (s, 9H), δ 0.57 (s, 6H). 
13
C NMR (100 MHz, CDCl3): δ 173.4, 172.8, 170.16, 167.9, 167.59, 151.8, 150.7, 137.8, 132.3, 
129.7, 129.5, 125.0, 121.1, 115.9, 61.7, 61.6, 52.7, 52.6, 48.2, 26.2, 25.2, 14.0, 13.8, -4.23. 
HRMS (ESI-TOF) m/z calcd. for C27H34N2NaO8Si ([M+Na]
+) 565.1977, found 565.1980. 
 
1,1-diethyl 2-methyl 2-(1,3-dioxo-2-phenyl-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-4-yl) ethane-
1,1,2-tricarboxylate (4r): Prepared following the general procedure outlined above using methyl 3-
(phenyl amino) acrylate, 1a (17.7 mg, 0.1 mmol, 1 equiv.), diethyl bromomalonate 2a (90 % purity, 
22.7 μL, 0.12 mmol, 1.2 equiv.), 1-phenyl-1H-pyrrole-2,5-dione, 3r (52 mg, 0.3 mmol, 3 equiv.),  
fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 
mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by column 






H NMR (400 MHz, CDCl3): δ 8.89 (d, 1H, J = 8.3 Hz) δ 8.14 (d, 1H, J = 8.5 Hz) δ 7.91 (ddd, 1H, J 
= 1.4 Hz, 7.0 Hz, 8.4 Hz) δ 7.77 (m, 1H) δ 7.57 – 7.32 (m, 5H) δ 5.85 (d, 1H, J = 9.5 Hz) δ 4.78 (d, 
1H, J = 9.5 Hz) δ 4.32 (qd, 2H, J = 1.6 Hz, 7.1 Hz) δ 4.06 (qd, 2H, J = 3.0 Hz, 7.1 Hz) δ 3.67 (s, 3H) δ 
1.34 (t, 3H, J = 7.1 Hz) δ 1.11 (t, 3H, J = 7.1 Hz). 
13
C NMR (100 MHz, CDCl3): δ 170.0, 167.9, 167.6, 166.9, 166.6, 152.0, 151.1, 135.8, 134.1, 132.8, 
131.1, 129.9, 129.1, 128.3, 127.9, 126.5, 126.0, 125.0, 121.9, 121.0, 61.8, 61.7, 52.8, 52.7, 48.2, 14.0, 
13.8. 
HRMS (ESI-TOF) m/z calcd. for C27H24N2NaO8 ([M+Na]
+) 527.1425, found 527.1425. 
 
1,1-diethyl 2-methyl 2-(2-(4-methoxyphenyl)-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolin-4-
yl)ethane-1,1,2-tricarboxylate (4s): Prepared following the general procedure outlined above using 
methyl 3-(phenyl amino) acrylate, 1a (17.7 mg, 0.1 mmol, 1 equiv.), diethyl bromomalonate 2a (90 % 
purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), 1-(4-methoxyphenyl)-1H-pyrrole-2,5-dione, 3s (60.9 mg, 0.3 
mmol, 3 equiv.),  fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 
equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by 




H NMR (400 MHz, CDCl3): δ 8.88 (d, J = 8.4 Hz, 1H), δ 8.13 (d, J = 8.6 Hz, 1H), δ 7.90 (ddt, J = 
8.3, 6.9, 1.3 Hz, 1H), δ 7.77 (ddt, J = 8.4, 6.9, 1.4 Hz, 1H), δ 7.40 (d, J = 8.7 Hz, 1H), δ 7.04 (d, J = 
9.1 Hz, 1H), δ 5.84 (d, J = 9.5 Hz, 1H), δ 4.78 (d, J = 9.5 Hz, 1H), δ 4.32 (qd, J = 7.1, 1.6 Hz, 2H), δ 
4.05 (qd, J = 7.1, 2.4 Hz, 2H), δ 3.86 (s, 3H), δ 3.66 (s, 3H), δ 1.34 (t, J = 7.1 Hz, 2H), δ 1.11 (t, J = 




C NMR (100 MHz, CDCl3): δ 170.09, 167.9, 167.1, 166.8, 159.3, 151.9, 151.0, 135.9, 132.78, 
129.8, 127.9, 125.0, 123.7, 122.0, 121.08, 114.4, 61.79, 61.70, 55.52, 52.8, 52.7, 48.2, 14.07, 13.87. 
HRMS (ESI-TOF) m/z calcd. for C28H26N2NaO9 ([M+Na]
+) 557.1531, found 557.1533. 
 
1,1-diethyl 2-methyl 2-(2-(4-(methoxycarbonyl)phenyl)-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-
c]quinolin-4-yl)ethane-1,1,2-tricarboxylate (4t): Prepared following the general procedure outlined 
above using methyl 3-(phenyl amino) acrylate, 1a (17.7 mg, 0.1 mmol, 1 equiv.), diethyl 
bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), methyl 4-(2,5-dioxo-2,5-dihydro-
1H-pyrrol-1-yl)benzoate, 3t (69.3 mg, 0.3 mmol, 3 equiv.),  fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 
equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 





H NMR (400 MHz, CDCl3): δ 8.89 (d, J = 8.4 Hz, 1H), δ 8.21 (d, J = 8.7 Hz, 2H), δ 8.15 (d, J = 8.5 
Hz, 1H), δ 7.93 (ddd, J = 8.5, 6.9, 1.4 Hz, 1H), δ 7.80 (ddd, J = 8.2, 7.0, 1.1 Hz, 1H), δ 7.66 (d, J = 
8.7 Hz, 2H), δ 5.85 (d, J = 9.6 Hz, 1H), δ 4.79 (d, J = 9.6 Hz, 1H), δ 4.33 (qd, J = 7.1, 1.7 Hz, 2H), δ 
4.10 – 4.01 (m, 2H), δ 3.96 (s, 3H), δ 3.67 (s, 3H), δ 1.35 (t, J = 7.1 Hz, 3H), δ 1.11 (t, J = 7.1 Hz, 
3H). 
13
C NMR (100 MHz, CDCl3): δ 170.0, 167.8, 167.6, 166.4, 166.2, 166.1, 152.1, 151.1, 135.6, 135.3, 
133.0, 130.4, 130.1, 129.9, 129.5, 125.9, 124.9, 121.8, 121.0, 61.86, 61.77, 52.81, 52.78, 52.33, 48.21, 
14.07, 13.87. 
HRMS (ESI-TOF) m/z calcd. for C29H26N2NaO10 ([M+Na]
+) 585.1480, found.585.1483. 
 
1,1-diethyl 2-methyl 2-(2-(benzyloxy)-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolin-4-
yl)ethane-1,1,2-tricarboxylate (4u): Prepared following the general procedure outlined above using 
methyl 3-(phenyl amino) acrylate, 1a (17.7 mg, 0.1 mmol, 1 equiv.), diethyl bromomalonate 2a (90 % 
purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), 1-(benzyloxy)-1H-pyrrole-2,5-dione, 3u (60.9 mg, 0.3 mmol, 
3 equiv.),  fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), 
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acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by column 




H NMR (400 MHz, CDCl3): δ 8.75 (d, J = 7.8 Hz, 1H), δ 8.08 (d, J = 8.5 Hz, 1H), δ 7.91 – 7.85 (m, 
1H), δ 7.74 (ddd, J = 8.2, 6.9, 1.2 Hz, 1H), δ 7.60 – 7.54 (m, 2H), δ 7.39 (m, 3H), δ 5.71 (d, J = 9.6 
Hz, 1H), δ 5.27 (s, 2H), δ 4.74 (d, J = 9.6 Hz, 1H), δ 4.32 (q, J = 6.4 Hz, 2H), δ 4.03 (qd, J = 7.1, 5.7 
Hz, 2H), δ 3.64 (s, 3H), δ 1.35 (t, J = 7.1 Hz, 3H), δ 1.08 (t, J = 7.1 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 169.8, 167.8, 167.4, 163.2, 163.0, 151.4, 151.1, 133.5, 132.99, 
132.98, 131.6, 129.96, 129.96, 129.91, 129.8, 129.4, 128.6, 124.8, 120.5, 119.1, 80.1, 61.8, 61.7, 
52.75, 52.73, 48.1, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C28H26N2NaO9 ([M+H]
+) 535.1711, found 535.1708. 
 
1,1-diethyl 2-methyl 2-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-1,3-dioxo-2,3-dihydro-1H-
pyrrolo[3,4-c]quinolin-4-yl)ethane-1,1,2-tricarboxylate (4v): Prepared following the general 
procedure outlined above using methyl 3-(phenyl amino) acrylate, 1a (17.7 mg, 0.1 mmol, 1 equiv.), 
diethyl bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), [1,1'-bipyrrole]-2,2',5,5'-
tetraone, 3v (57.6 mg, 0.3 mmol, 3 equiv.),  fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 
(17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 




H NMR (400 MHz, CDCl3): δ 8.91 (ddd, J = 8.4, 1.5, 0.7 Hz, 1H), δ 8.16 (ddd, J = 8.6, 1.3, 0.7 Hz, 
1H), δ 7.93 (ddd, J = 8.6, 6.9, 1.5 Hz, 1H), δ 7.80 (ddd, J = 8.2, 6.9, 1.2 Hz, 1H), δ 7.73 (s, 2H), δ 
5.87 (d, J = 9.6 Hz, 1H), δ 4.80 (d, J = 9.6 Hz, 1H), δ 4.34 (qd, J = 7.1, 1.7 Hz, 2H), δ 4.07 (qt, J = 




C NMR (100 MHz, CDCl3): δ 170.0, 167.8, 167.6, 166.6, 166.3, 152.1, 151.1, 135.7, 132.9, 130.8, 
130.0, 129.9, 126.9, 125.0, 121.9, 121.0, 61.8, 61.7, 52.8, 52.7, 48.2, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C25H21N3NaO10 ([M+Na]
+) 546.1119, found 546.1116. 
 
1,1-diethyl 2-methyl 2-(3,4-dicyano-6-methoxyquinolin-2-yl) ethane-1,1,2-tricarboxylate (4w): 
Prepared following the general procedure outlined above using methyl 3-((4-methoxyphenyl) amino) 
acrylate, 1g (20.7 mg, 0.1 mmol, 1 equiv.), diethyl bromomalonate 2a (90 % purity, 22.7 μL, 0.12 
mmol, 1.2 equiv.), fumaronitrile 3w (23.3 mg, 0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 
0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 





H NMR (400 MHz, CDCl3): δ 8.01 (d, 1H, J = 9.3 Hz) δ 7.59 (dd, 1H, J = 2.7 Hz, 9.3 Hz) δ 7.36 (d, 
1H, J = 2.7 Hz) δ 5.19 (d, 1H, J = 10.4 Hz) δ 4.74 (d, 1H, J = 10.4 Hz) δ 4.31 (qd, 2H, J = 2.4 Hz, 7.1 
Hz) δ 4.08 – 3.97 (m, 5H) δ 3.68 (s, 3H) δ 1.33 (t, 3H, J = 7.1 Hz) δ 1.09 (t, 3H, J = 7.1 Hz) 
13
C NMR (100 MHz, CDCl3): δ 168.9, 167.3, 166.8, 161.2, 152.6, 144.4, 131.7, 127.8, 125.9, 122.2, 
114.0, 113.2, 111.3, 102.0, 62.1, 62.0, 56.2, 53.1, 53.0, 50.4, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C22H21N3NaO7 ([M+Na]
+) 462.1272, found 462.1275.  
 
1,1-diethyl 2-methyl 2-(4-cyano-3-(ethoxycarbonyl)-6-methoxyquinolin-2-yl)ethane-1,1,2-
tricarboxylate (4x) and 1,1-diethyl 2-methyl 2-(3-cyano-4-(ethoxycarbonyl)-6-methoxyquinolin-
2-yl)ethane-1,1,2-tricarboxylate (4x’) Prepared following the general procedure outlined above 
using methyl 3-((4-methoxyphenyl) amino) acrylate, 1g (20.7 mg, 0.1 mmol, 1 equiv.), diethyl 
bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), (Z)-ethyl 3-cyanoacrylate 3x (62.5 
mg, 0.5 mmol, 5 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 
1.2 equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by 
column chromatography yielded the pure product. (50 % yield, 4x : 4x’ = 2 : 1). 
 







H NMR (400 MHz, CDCl3): δ 7.96 (d, J = 9.2 Hz, 1H), δ 7.51 (dd, J = 9.2, 2.7 Hz, 1H), δ 7.44 (d, J 
= 2.7 Hz, 1H), δ 5.53 (d, J = 9.5 Hz, 1H), δ 4.71 (d, J = 9.5 Hz, 1H), δ 4.60 (qd, J = 7.2, 2.4 Hz, 2H), 
δ 4.29 (qd, J = 7.1, 0.9 Hz, 2H), δ 4.05 (q, J = 7.0 Hz, 2H), δ 4.01 (s, 3H), δ 3.65 (s, 3H), δ 1.53 (t, J = 
7.2 Hz, 3H), δ 1.33 (t, J = 7.1 Hz, 3H), δ 1.07 (t, J = 7.1 Hz, 3H).  
13
C NMR (100 MHz, CDCl3): δ 170.2, 168.1, 167.5, 164.6, 160.5, 150.3, 143.6, 131.4, 128.7, 126.4, 
125.9, 117.9, 114.3, 102.4, 63.1, 61.7, 61.6, 56.0, 53.1, 52.6, 49.3, 14.0, 13.88, 13.85. 
HRMS (ESI-TOF) m/z calcd. for C24H26N2NaO9 ([M+Na]
+) 509.1531, found 509.1530. 
 





H NMR (400 MHz, CDCl3): δ 7.96 (d, J = 9.3 Hz, 1H), δ 7.50 (dd, J = 9.3, 2.8 Hz, 1H), δ 7.39 (d, J 
= 2.7 Hz, 1H), δ 5.26 (d, J = 10.4 Hz, 1H), δ 4.77 (d, J = 10.4 Hz, 1H), δ 4.64 (qd, J = 7.1, 1.4 Hz, 
2H), δ 4.31 (qd, J = 7.1, 1.0 Hz, 2H), δ 4.01 (qd, J = 7.1, 5.9 Hz, 2H), δ 3.94 (s, 3H), δ 3.68 (s, 3H), δ 
1.54 (t, J = 7.2 Hz, 3H), δ 1.34 (t, J = 7.1 Hz, 3H), δ 1.06 (t, J = 7.1 Hz, 3H).  
13
C NMR (100 MHz, CDCl3): δ 169.5, 167.6, 166.9, 164.4, 159.8, 152.6, 144.7, 141.8, 131.4, 126.1, 
123.5, 115.1, 106.5, 102.6, 63.3, 61.9, 61.8, 55.7, 53.4, 52.9, 50.2, 14.06, 14.01, 13.78. 
HRMS (ESI-TOF) m/z calcd. for C24H26N2NaO9 ([M+Na]
+) 509.1531, found 509.1530. 
 
(E)-1,1-diethyl 2-methyl 2-(6-methoxy-3-(3-methoxy-3-oxoprop-1-en-1-yl)-4-
(methoxycarbonyl)quinolin-2-yl)ethane-1,1,2-tricarboxylate (4z): Prepared following the general 
procedure outlined above using methyl 3-((4-methoxyphenyl) amino) acrylate, 1g (20.7 mg, 0.1 
mmol, 1 equiv.), diethyl bromomalonate 2a (90 % purity, 22.7 μL, 0.12 mmol, 1.2 equiv.), (E)-
dimethyl hex-2-en-4-ynedioate, 3z (50.4 mg, 0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 mmol, 
0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), DDQ (93 mg, 0.41 mmol, 4.1 
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H NMR (400 MHz, CDCl3): δ 8.11 (d, J = 16.2 Hz, 1H), δ 7.93 (d, J = 9.2 Hz, 1H), δ 7.39 (dd, J = 
9.2, 2.7 Hz, 1H), δ 7.11 (d, J = 2.7 Hz, 1H), δ 6.26 (d, J = 16.2 Hz, 1H), δ 5.11 (d, J = 10.4 Hz, 1H), δ 
4.81 (d, J = 10.4 Hz, 1H), δ 4.27 (qd, J = 7.1, 1.0 Hz, 2H), δ 4.00 (q, J = 7.1 Hz, 2H), δ 3.94 (s, 3H), δ 
3.90 (s, 3H), δ 3.85 (s, 3H), δ 1.31 (t, J = 7.1 Hz, 3H), δ 1.01 (t, J = 7.1 Hz, 3H).   
13
C NMR (100 MHz, CDCl3): δ 170.4, 168.3, 167.6, 167.5, 165.7, 158.8, 149.0, 143.3, 140.0, 139.8, 
131.4, 126.4, 125.6, 125.3, 123.5, 102.6, 61.7, 61.4, 55.7, 53.3, 52.7, 52.5, 52.1, 49.6, 14.0, 13.8. 
HRMS (ESI-TOF) m/z calcd. for C26H29NNaO11 ([M+Na]
+) 554.1633, found 554.1635. 
 
methyl 3,3,4,4,5,5,5-heptafluoro-2-(8-methoxy-2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-
c] quinolin-4-yl) pentanoate (4aa): Prepared following the general procedure outlined above using 
methyl 3-((4-methoxyphenyl) amino) acrylate, 1g (20.7 mg, 0.1 mmol, 1 equiv.), heptafluoropropyl 
iodide, 2aa (28.8 μL, 0.2 mmol, 2 equiv.), N-methyl maleimide 3a (33.3 mg, 0.3 mmol, 3 equiv.), fac-
Ir(ppy)3 (2 mg, 0.003 mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), acetone (2 mL), 
DDQ (93 mg, 0.41 mmol, 4.1 equiv.) and toluene (2 mL). Purification by column chromatography 




H NMR (400 MHz, CDCl3): δ 8.15 (d, 1H, J = 9.4 Hz) δ 8.07 (d, 1H, J = 1.9 Hz) δ 7.56 (dd, 1H, J = 
9.4 Hz, 1.7 Hz) δ 6.13 (dd, 1H, J = 11.7 Hz, 16.9 Hz) δ 4.02 (s, 3H) δ 3.74 (s, 3H) δ 3.25 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 167.9, 167.8, 164.4, 161.2, 148.4, 134.1, 132.0, 127.0, 123.15, 
122.5, 101.0, 56.06, 52.9, 48.9, 48.7, 48.5, 29.2, 24.1, 23.6. 
19
F NMR (376 MHz, CDCl3): δ -80.43 (t, J = 10.5 Hz, 3F) δ -110.45 (d, J = 301.1 Hz, 1F) δ -112.85 
(d, J = 301.1 Hz, 1F) δ -123.71 (ddd, J = 287.7 Hz, 10.6 Hz, 1.8 Hz, 1F) δ -124.72 (ddd, J = 287.7 Hz, 
10.5 Hz, 1.2 Hz, 1F) 
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HRMS (ESI-TOF) m/z calcd. for C19H13F7N2NaO5 ([M+Na]
+) 505.0605, found 505.0606. 
 
methyl 3,3,3-trifluoro-2-(8-methoxy-2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolin-
4-yl)propanoate (4ab): Prepared following the general procedure outlined above using methyl 3-((4-
methoxyphenyl) amino) acrylate, 1g (20.7 mg, 0.1 mmol, 1 equiv.), Togni’s reagent II, 2ab (63.2 μL, 
0.2 mmol, 2 equiv.), N-methyl maleimide 3a (33.3 mg, 0.3 mmol, 3 equiv.), fac-Ir(ppy)3 (2 mg, 0.003 
mmol, 0.03 equiv.), Na2HPO4 (17 mg, 0.12 mmol, 1.2 equiv.), Acetone (2 mL), DDQ (93 mg, 0.41 
mmol, 4.1 equiv.) and toluene (2 mL). Purification by column chromatography yielded the pure 




H NMR (400 MHz, CDCl3): δ 8.12 (d, J = 9.4 Hz, 1H), δ 8.07 (d, J = 2.8 Hz, 1H), δ 7.56 (dd, J = 
9.4, 2.9 Hz, 1H), δ 5.94 (q, J = 8.2 Hz, 1H), δ 4.03 (s, 3H), δ 3.78 (s, 3H), δ 3.26 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ 168.0, 167.8, 161.1, 148.4, 142.3, 134.2, 131.8, 126.9, 124.6, 123.2, 
122.4, 121.8, 101.1, 56.0, 52.9, 52.4-51.6 (q), 24.1 
19
F NMR (376 MHz, CDCl3): δ -65.08 (d, J = 8.2 Hz, 3F). 
HRMS (ESI-TOF) m/z calcd. for C17H13F3N2NaO5 ([M+H]





3.8.8. Control experiments 
 
3.8.8.1. Control experiment (2) 
 




3.8.8.2. Control experiment (3) 
 
1
H NMR (400 MHz, CDCl3): δ 4.92 (s, 1H), δ 4.25 (q, J = 7.1 Hz, 4H), δ 1.65 – 1.38 (m, 6H), δ 1.29 
(t, J = 7.1 Hz, 6H), δ 1.20 (s, 6H), δ 1.08 (s, 6H). NMR data is consistent with the reported data. 
 
Figure 3-11. HRMS data of E and F. 
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3.8.9. Procedure for visible-light on/off experiment 
 
To an oven-dried 4 mL vial equipped with a stir bar was added photocatalyst fac-Ir(ppy)3 
(2.0 mg, 3 μmol, 0.03 equiv.), sodium ascorbate (39.6 mg, 0.2 mmol, 2 equiv.), anhydrous sodium 
phosphate dibasic (powder) (17 mg, 0.12 mmol, 1.2 equiv.), methyl 3-(phenyl amino) acrylate 1a 
(17.7 mg, 0.1 mmol, 1 equiv.) and N-methyl maleimide 3a (33.3 mg, 0.3 mmol, 3 equiv.). Required 
amounts of anhydrous acetone (2 mL) and diethyl bromomalonate 2a (90 % purity, 22.7 μL, 0.12 
mmol, 1.2 equiv.) were added under argon atmosphere in glovebox. Trichloroethylene (27 uL, 0.3 
mmol, 3 equiv.) was added as internal standard. The reaction mixture was irradiated with a 12 W blue 
LED lamp (5 cm away, 25 °C maintained with a cooling fan). Yields were determined by 1H NMR 
spectroscopy with trichloroethylene as an internal standard at every 4 hours. 
 
3.8.10. Cyclic voltammetry data 
 
3.8.10.1. 4-methoxy-N,N-diphenylaniline  
 
(E1/2
ox = + 0.78 V vs SCE in MeCN at 25°C) 
 














3.8.11. NMR spectra 
methyl 3-(phenylamino)acrylate (1a) 
 




methyl 3-(o-tolyl amino) acrylate (1c) 
 




methyl 3-((4-bromophenyl) amino) acrylate (1e) 
 




methyl 3-((4-methoxyphenyl) amino) acrylate (1g) 
 




methyl 3-((4-hydroxyphenyl) amino) acrylate (1i) 
 




methyl 3-((2-((tert-butoxycarbonyl)amino)phenyl)amino)acrylate (1k) 
 













































(Z)-ethyl 3-cyanoacrylate (3x) 
 










Togni’s reagent II (2ab) 
 













































































1,1-diethyl 2-methyl 2-(8-(methoxy carbonyl)-2-methyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo [3,4-c] 
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고등학교를 졸업한 후, 낯선 타지의 UNIST 에 입학하고 학부 생활과 더불어 대학원 
생활까지 10 년이란 긴 시간이 지났습니다. 청춘이라는 두 글자가 가장 어울리는 20 대, 그 
젊음을 함께한 UNIST 를 떠나야할 날이 이제는 도래하였습니다. 즐거웠던 기억을 뿐만 아니라 
힘들었던 그리고 포기하고 싶었던 여러 순간들에 도움을 주셨던 많은 분들께 떠남에 앞서 감사의 
말씀을 전하고자 합니다. 
우선, 학부 3 학년때부터 인턴십을 시작으로, 대학원에 진학하여 학위를 마칠 때까지 
아낌없는 가르침과 따끔한 지도로 저를 이끌어주신 저의 지도 교수님 박철민 교수님께 무한한 
감사의 말씀을 올립니다. 처음 연구실에 발을 들이고 스포이드 하나 쉽게 쥐지 못하는 저를, 한 
명의 연구자로 키워주셔서 감사드립니다. 부족한 면이 너무나도 많아 많은 실망과 더불어 심려를 
끼쳐드려서 죄송합니다. 포기할 수 있었던 많은 순간에도 저를 제자로서 아껴주시고 끝까지 
이끌어주신 것에 깊은 감사의 말씀을 드립니다. 정직하고 성실하지 못했던 모습은 반성하고 
교수님의 가르침을 따라 교수님의 명성에 누가 되지 않도록 명심하며 노력하며 살겠습니다. 지도 
교수로서 교수님의 헌신적인 지원을 은혜로 생각하며 발전하는 연구자가 되도록 열정을 다해 
임하도록 하겠습니다. 
다음으로, 바쁘신 와중에 저의 박사학위심사의 심사위원으로 자리 해주신 최원영 
교수님, 홍성유 교수님, 박영석 교수님 그리고 울산대 우상국 교수님께 영광의 말씀을 올립니다. 
교수님들께서 남겨주신 조언들을 바탕으로 저의 지난 연구 생활을 돌이켜보게 되었습니다. 
연구자로서의 부족한 부분을 깊이 고민해보고 앞으로 나아갈 방향을 생각하며 더욱 성장하는 
계기가 되었습니다. 다시 한 번 자리해 주셔서 감사드립니다.  
아울러, 연구실 생활을 하며 인연이 되었던 많은 사람들에게 안녕의 인사를 전합니다. 
함께 대학원에 입학하여 지난 긴 시간을 함께 보낸 동기 하수진 그리고 이양하 에게 수고했다는 
말을 전합니다. 그리고 프로젝트를 같이 임했던 오현지, 김민주, 박진휘 에게도 그동안 고생 
많았고 함께 연구를 진행하여 즐거웠다는 인사를 전합니다. 그 밖에, 연구를 함께 진행하지는 
않았지만 동고동락하며 지내왔던 최수빈, 심정우, 류보경, 유은수, 김형국, 이창주, 최민영, 
최유라, 홍은애에게 함께하는 시간 동안 즐거웠다는 인사를 전합니다. 
그리고, 형제자매와 같이 입학하기 전부터 졸업하는 순간까지 동병상련을 느끼며 옆에서 
응원해준 많은 친구들에게 감사의 인사를 전합니다. 비록 이제 캠퍼스를 떠나 각자의 길로 
나아가겠지만, 함께했던 우리의 지난 날들은 평생 잊지못한 순간들로 충만하였음을 기억합니다. 
끝으로, 언제나 저를 믿어주고 응원해주었던 나의 가족들에게 감사의 말을 전합니다. 
아낌없는 지원과 더불어, 할 수 있다는 믿음을 주신 덕에 무사히 학위를 마치게 되었습니다. 
자랑스런 작은 아들로 성장할 때까지 긴 세월을 기다려주셔서 감사합니다. 늘 사랑합니다.
 
 
